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INTRODUCTION 
                Siddha  system  of  medicine  is  the ancient, unique & potent system  among  
all the  system. Siddha  is  a well-defined  medical  science through  which  the  body 
as well as the  soul  is  treated. In this  system  of  medicine, all  the systemic diseases 
are classified  based  on  the vitiation of  three  humours, symptoms, line of treatment. 
               Siddha system is based on the concept of “FOOD ITSELF IS MEDICINE”. 
This system emphasizes about a healthy body, pure soul and peaceful mind. Hence it 
is unique when compared to any other medical system.  
              The main aim of this system is “PREVENTION IS BETTER THAN CURE”.  
Dietary and life style modifications play a major role in curing all the diseases. Due to 
dietary imbalance there is a variation  in  three thodams and brings about “Pitha 
Paandu”.   
               According to Siddhars classification there are 4448 types of disease. Vellupu 
noi or Paandu noi  is one of  the major disease  affecting  women.
(1) 
               According  to WHO, Anaemia is a condition in which the haemoglobin 
content of  blood is lower than normal as a result of nutritional deficiency.
(2) 
As per 
modern science, Anaemia is not classified  as  a  disease but  it is a disorder which can 
affect pshychological and physical behaviour. Iron deficiency usually develops slowly 
& insidiously with no specific complaints. 
             According to Yugi Vaidya Chindamani there are six types of Paandu.
(3) 
Based 
on this classification “Pitha Paandu”  is  discussed  in  this  work.  The symptoms of 
Iron deficiency anaemia are correlated with Azhal  veluppu noi or Pitha paandu noi. 
           Nutritional Iron deficiency is the most common & widespread micro nutritional 
disorder in the world. Approximately one third of the global population is known to 
affected by Iron deficiency and  it is a very common nutritional disorder in 
worldwide
(4)
. Iron demand is high in menstruation & pregnant females. 
            Hypochromic anaemia due to iron deficiency is the commonest cause of 
anaemia in the world over and estimated about 20% in women and 2% in adult 
males.
(5)
 Anaemia develops when the supply of Iron is inadequate for the requirement 
of Haemoglobin synthesis.
(6) 
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          Around 30% of the total world population is anaemic and half of these, 600 
million people have Iron deficiency anaemia.
(7)
 Iron deficiency anaemia  is common in 
our country, because most of the people in our country are suffered from 
undernutrition unknowingly. 
            During pregnancy, it  is  estimated  that  1200 mg  of  iron are required from 
conception through delivery. Micronutrient deficiency and especially Iron deficiency 
is believed to be underlying cause for anaemia.These are often referred  as  „hidden 
hunger‟  because  they  develop  gradually  over  time. 
           In India, the prevalence of anaemia is high due to low dietary intake, poor 
intake of Iron coupled  with  poor  bioavailability. Globally, anaemia affects 1.62 
billion people. According to  Indian  council  of  Medical Research (ICMR) surveys, 
prevalence of anaemia is very high in preschool children (80>90%) and adolescence 
girl.
(8)
 
           As per National Family Health Survey (NFHS) nearly 50 - 80% of Indian 
mothers suffer from anaemia due to Iron deficiency.
(9)
 It occurs due to decreased 
production of RBC & increased destruction of RBC. The major cause for anaemia  is  
imbalanced diet and poor nutritional status. In Siddha system this condition is called 
Paandu or Velluppu Noi
. 
           According  to  UNICEF  report  two  billion  people  suffer  from  anaemia, 
where 40-50%  of children under age 5 are Iron deficient. It may cause a permanent 
loss of  IQ in infants, difficulty with concentration, lethargy, poor mental development 
& learning capacity.
(10)
 
          The drugs used in Siddha medicine were classified on the basis of five 
properties: Suvai (taste), Guna (character), Veerya (potency), Pirivu (class) and 
Mahima (action). Proper diet, Medicine and a disciplined regimen of  life are advised 
for a healthy living  and to restore equilibrium of humours in diseased condition. 
           In traditional system of medicines there are several herbs use to manage Iron 
deficiency anaemia.  I  have  chosen “SARAKONDRAI CHOORANAM”  a  purely 
herbal medicine used to treat Iron deficiency anaemia in this project. 
 
 
 
 
 
 
 
 
 
 
AIM  AND  
OBJECTIVES 
3 
 
AIM  AND OBJECTIVES 
AIM: 
The  aim  of  the study  is  the management  of  PITHA PAANDU (Iron 
deficiency anaemia), both clinically  and  experimentally  with  the  Siddha drug 
“SARAKONDRAI CHOORANAM”   as  referred  in  “Athma Ratchamirtham Ennum 
Vaithya Sara Sangraham”. 
OBJECTIVES:    
 To collect the literature of both Siddha and Modern aspect of the disease, Pitha 
paandu  and establish a correlation between them. 
 To study the Efficacy and Safety of Sarakondrai Chooranam in the 
management of  Pitha paandu. 
 To study the Clinical course of the disease with observation on Etiology, 
Classification, Pathology, Prognosis, Complications and Treatment by Siddha 
aspect. 
 To evaluate the Pathology  of  Pitha paandu noi by concentrating Mukkutram, 
Poripulangal, Udalkattugal  and  Envagaithervu. 
 To have an idea about the  incidence of the disease with Age, Occupation, 
Socio- economic status, Habits and Climate conditions. 
 To have the Modern Parameters to confirm the Diagnosis and Prognosis of the 
disease. 
 To have a Clinical trial on the disease Pitha Paandu  with the Siddha drug 
Sarakondrai Chooranam. 
 To evaluate the 
 Physico chemical  analysis. 
 Bio chemical analysis. 
 Toxicological (Acute and Sub-acute). 
 Pharmacological studies (Haematinic activity in Phenyl 
hydrazine   induced anaemia in wistar albino rat). 
 Bio-statistical analysis of trial medicine. 
 
 
  
 
 
REVIEW 
OF 
LITERATURE 
 
 
 
  
 
 
 
SIDDHA ASPECT 
 
 
4 
 
             SIDDHA  ASPECT 
 VERUPEYAR (SYNONYMS) 
         Velluppu noi , Venmai noi, Ven pandam. 
IYAL (DEFINITION) 
        Vellupu  noi   is  a  disease of “ Ratha Thathu”  characterized  by  the  change  of  
colour of  skin, conjunctiva, nails and tongue.
(11) 
As  per  “AGASTHIYAR VAITHIYA KAAVIYAM”, 
         “க஫ி஬ாகுந் த஡க஥ப்தா கா஠த்஡ச ஬த்஡ாய்  
         ஬ற்நி஬ிடு ஥ன்ண஬ாசல் தகட்கில் 
         த஫ிகா஧ர் ப௃கத்஡ிணில் ப௃஫ி஦ார் ததான தாண்டம஥ல்னாம் 
         ம஬ளுக்கடித்஡து ஧த்஡ம்” 
-Agasthiyar Vaithiya Kaaviyam  
     As per the above literature Pandu noi  is  a condition  with  the  features  of  pallor  
of  the  conjunctiva, nail buds  and  body  due  to  reduction  in the haemoglobin 
concentration of  the blood. 
AETIOLOGY 
Increased  intake  of  salt, bitter foods, 
Fever, 
Diarrhoea, 
Vomitting, 
Kilvayu, 
Menorrhagia, 
Hypertension, 
Dysentry, 
Bleeding Piles, 
Blood Vomitting, 
5 
 
Blood loss due to trauma, 
Excess intake of toxic substances, 
Helminthitic infections, 
Fatigue, 
Tuberculosis, 
Amoebic dysentery, 
Liver disease, 
Tobacco, betel  leaf  chewing, arecanut,  
Excessive intake of  sand, ashes, sacred ashes and  camphor.
(12)
 
These  are  the  factors  for  the  disease Veluppunoi.
 
MIRKURIGUNANGAL: 
         The pitha  thodam  becomes excessive in activity due to factors such as diet and 
impairs  the colour and volume of the blood. In addition, it also makes the body pale 
without affecting the nutritional requirement of the body. Later patient  may develop 
fatigue of  legs even walking  for  a short distance, dyspnoea, anorexia, nausea, 
giddiness, dimness  of  vision, frequent  fainting, palpitation and emaciation of the 
body.
 
           Siddhars  explains  the causes  of  Veluppu  noi  in  many of  their text, 
As  per “Yugi Vaithiya Chinthaamani” 
“அநிந்துத஥ உற்தத்஡ி மசால்னக் தகபாய் 
அ஡ிசா஧ ஥ன஥ிபகி ஋ந்த஢ ஧ந்஡ான் 
திநிந்துத஥ புபிப௅ப்பு மதருத்஡ னாலும் 
மதத்஡஥ா ஥க்கிணி ஦ிருத்஡ னாலும் 
஥ிநிந்து஡ாம் பூன஥ிக அருந்஡ னாலும் 
஥ீநித஦ ஥துக்களபத்஡ான் புசித்஡னாலும் 
தநிந்துத஥ தகல்஢ித்஡ிள஧ மசய்஡னாலும் 
தாண்டு஬ந்து தாரிலுள்தபார் தடும் தாதட”  
                -Yugi Vaithiya Chinthaamani.
(13) 
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 Frequent dysentery, 
 Excess intake of salt and sour items,  
 Excess intake of  betal leaves and arecanut, 
 Excess heat production, 
 Alcohol intake and sleeping in day time. 
 
According to “Agasthiyar Gunavagaam,” 
                 “ தேரடா த஡கத்஡ிதன இ஧த்஡ம் ஬ற்நித் 
            ஡ீங்காண ஬ிந்஡த஢ாய் காணு஥ப்தா 
                               மகாள்படா அதக்கு஬ ததாசணத் ஡ிணாலும் 
குடிமகடுத்஡ மதரும்தாடு கி஧ா஠ி஦ாலும்  
கள்படா கருப்தத்஡ின் கி஧ந்஡ி஦ாலும் 
கண஥ாண ஧த்஡த்஡ின் ததாக்கிணாலும் 
அள்படா அ஡ி஦ா஥ க஬ணத்஡ாலும் 
அப஬ற்ந஬ி சா஧ந்஡ாணளடப௅ம் ததாதும் 
ம஡ள்பத஬ த஡கத்஡ில் இ஧த்஡ம் மகட்டு 
ம஡பி஬ாண தாண்டதுவு ப௃ண்டாம் தாத஧”  
           -Agasthiyar Gunavaagadam.(14) 
 
 Imperfect cooking,  
 Menorrhagia, 
 Dysentery,  
 Congenital disease,  
 Bleeding disorders,  
 Insomnia, 
 Over depression causes paandu. 
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According to “Dhanvanthiri’s Vaithiyam” 
“஡ிருந்஡ிடும் தாண்டுத஧ாகஞ் தசர்ந்஡ிடுங் கு஠த்ள஡க் தகபாய்  
இருத்஡ிடும் ஬ா஡தித்஡ச் சிதனற்தண ஥ிள஬஡ான் ஥ாறும் 
தரிந்து஡ா மணான்தநாடி மடான்றுமதாருந்து஬஡ாலும் ஥ண்த஠டரும்  
ஆகி஦ ப௄னந்஡ன்ணி னளணந்஡வுட் ட஠த்஡ிணாலும் 
த஡ாளக஦ர் த஥கத்஡ாலும் து஦ர்஥ிகு தசாகத்஡ாலும் 
த஡கததரிளண ப௅ள்தபார்க்குந் ஡ரித்஡ி஧ஞ் தசர்஡னாலும் 
த஬க஥ாந் ஡ிரித஡ா஭ங்கள் ஥ிஞ்சித஦ தாண்டு஬ாத஥”  
-Dhanvanthiri’s Vaithiyam.(15) 
 
 Derangement  of  thirithodam,  
 Excessive heat production in the body,  
 Gonorrheal diseases, 
 Stress, 
 Depression are the causes of anaemia. 
 
According to “Dhanvanthiri’s Vaithyam” 
“஌ய்த்஡ வுட்டி஠க் கானத்஡ில் ஋ழும்திடும் தித்஡ந்஡ன்ணில்  
சாய்த்஡ிடு உப்புப்புபிப்பு ஥ரிசண஡ாமணன்றும் த஡ார்த்஡ந்  
தசர்ந்து தித்஡ந்஡ான் மகட்டுசிதனற்தணம் மதாருந்஡ி஦த஡ார் 
தாய்ந்து ஬ண்஠ந்஡ன்ளண மகடுக்கும் ளதத்஡ி஦ தாண்டு஬ாத஥ ” 
               -  Dhanvanthiri’s Vaithiyam.(15) 
 
 Excessive heat, 
 Intake  of  excess  of  salt, sour taste food items affects pitha thaathu, 
 Selarpana thaathu  also  gets  affected,  
 Discolourations  of  skin  are features of  Pitha paandu. 
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In “Noi  Nadal Noimudal Nadal”  
“கிருமியால் வந்ேதோடம் பெருகவுண்டு 
தகட்கலேின் ெிரிவேனைக் கிரமமாக 
பொருமி வரும் வாயு வல்லாங் கிருமியாதல 
புழுக்கடி தொல் காணுமது கிருமியாதல 
பெருமிவரும் ெவுத்ேிரங்கல் கிருமியாதல 
தேகமேில் தொனகக் குட்டம் கிருமியாதல  
சூட்ெமுடன் கிரிமியனகத் போழில் பெய்வதீர’’  
 -Noi Nadal Noimudal Nadal Thirattu.
(16) 
 
           According  to this  Sobai occurs  due  to worm infestation which meant  
Vellupu noi.  
In  “Agasthiyar Kanmakaandam Gowmathi Nool , 
“஢ாம஥ன்று மசால்லுகிதநாம் தாண்டு ஬ந்஡ 
   ஢ன஥ாண ஡ரு஥஥து மசால்னக் தகளுச் 
஡ாம஥ன்ந ஡ாய்஡ந்ள஡ ஥ணம்த஢ாகச் மசய்஡ல் 
   ஡஧஠ி ஡ணிலுள்ப ஬ர்க்கும்஬ம்தத மசால்ன 
னாம஥ன்று வுறுப்த஫ித்஡ல் மச஬ி சு஬ாச 
  ஥ற்றும் மதாய் மசால்னாங் கா஧ஞ் மசய்஡ல் 
த஬ம஥ன்ந கரு஥஥து தித்஡ த஥நி 
  ம஬ளுத்துடன் ம஬ப்பு ஥ிஞ்சிக் ளககாதனாய்த஬”  
-Agasthiyar Kanmakaandam Gowmathi Nool.
(17) 
It  states that person who  insulting  parents  and  made harsh arguments, liar 
and doing activities increasing  pitham cause Paandu. 
   In “Agasthiyar Paripooranam” 
மசால்னா஡ கடி஬ி஭ங்கள் குன்஥ம் தாண்டு 
து஦ர்஡ீ஧ாக் கன்஥஬ிளண மசய்஡ தா஬ம் 
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஋ல்தனாரும் ஢ளகக்க உடம்மதடுத்஡ தா஬ி 
இன்ணப௃ண்டு ஬ித஧஥ாய் உனகிற் தகதப”  
-Agasthiyar Paripooranam.(18)
 
 
              This  quote  proves  that  Paandu noi  is  due  to  kanmavinai. 
NILAM: 
“குநிஞ்சி ஬ரு஢ினத்஡ிற் மகாற்நப௃ண்டி ஧த்஡ம் 
உநிஞ்சி ஬ருசு஧ ப௃ண்டாம் அநிஞள஧க் 
ளக஦த஥ ஡ங்கு஡஧த் ஡ாள஥ ஬ல்ளனப௅ங் க஡ிக்கும் 
஍஦த஥ ஡ங்கும் அநி” 
                                         -Siddha Marutuvanga Churukkam.
(19) 
According  to  this  people  who lives  in  mountain areas have more chances 
for  the  occurance of  Paandu noi. 
CLINICAL FEATURES:
 
      The  features  of  Paandu  noi  are explained  by  Siddhars  in  their text, 
In “Yugi Vaithiya Chinthaamani” 
“஬ாம஥ன்ந த஥ணிம஦ல்னாம் ஥ஞ்ச பித்து 
   ஥காம஬ளுப்பு உண்டாகி ஥ந்஡க் கண்஠ாய் 
஡ாம஥ன்ந ஡ாகம஥ாடு ப௄ர்ச்ளச ஦ாகுந் 
   ஡ணி஬ா஦ில் ஥ிபகுததாற் நானு ப௃ளநக்கும் 
த஢ம஥ன்ந ம஢ஞ்சுப௃ள் ஡ானு ப௃ண்டாய் 
   ம஢ருக்கித஦ ப௄ச்சுப௃ட்டதுத஬ ஦ாகும் 
தகாம஥ன்ந கிறுகிறுத்து ஬ாய்ளகப் தாகுங் 
   கிபர்தித்஡ தாண்டு ம஬ணக் கூநனாத஥”  
                   -Yugi Vaithiya Chinthaamani.
(20) 
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 Yellowish discolouration of body, 
 The tongue, the upper and lower limbs will become pale, 
 Paleness, dimness of vision, 
 Giddiness, 
 Bitter taste, 
 Excessive thirst, ulceration of mouth, 
 Dyspnoea, 
 Flatulence, 
 Bad odour in the mouth, 
 Frequent diarrhoea with stool appearing  yellow in colour, 
 Desire to eat cold diet. 
 
As  per  “Pararasasekaram” 
“தித்஡த்஡ி மனடுத்஡ தாண்டு ததச஢ா ஬நட்சிப௅ண்டாம் 
஥ற்றுடல் தசுள஥ ஦ாகி஥ஞ்சபி ணிநப௃ண்டாம் 
ஊற்நிடு ப௄ர்ச்ளச ஡ாகம஥ாபி மகடுங் கண்஠஥ாழும் 
தூற்நிடு ஥஫ற்சி ஬ா஦ிற்றுர்஢ாற்நம் புபித்த஡க்குண்டாம்  
 
இரு஥தன ஦ிளபப்பு ம஢ஞ்சினிடிப்புடன் உ஧ப்பு஥ாகிப் 
மதருகத஬ ஢டக்கும்ததாது ததசப௃ட்டதுத஬ ஦ாகும் 
ம஬றுவுநக் கிரு஥ிறுக்க த஥ணிப௅ம் ம஬ளுத்஡ள஡க்கும் 
மதருகித஦ தித்஡தாண்டு ஬ாம஥ண ததசிணாத஧  
 
ஊ஡ம஥ய் ஦ள஡த்துக் ளககாதனாய்ந்துடன் சு஧ந்துத஢ா஬ாகி 
புள஡஦த஬ ஬ஙீ்குங் கண்ணும்ததா஡த஬ த஬ளுக்குஞ் தசார்஬ாய் 
தா஡க஧ ஥கிலு஥ிஞ்சிச் மசாநி஬஡ா ஦சலுதற்றும் 
஬஡ீப௃று கு஠ங்கள் தித்஡தாண்மடண ஬ிபம்திணாத஧”  
                                                                                         -  Pararasasekaram.
(21) 
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 Dryness of mouth, 
 Greenish and yellowish discolouration of  body colour, 
 Lassitude, 
 Excessive thirst, 
 Bad odour in mouth, 
 Indigestion, 
 Cough, dyspnoe on exertion,  
 Paleness, 
 Cardiac murmurs,  
 Oedema of body and limbs, 
 Tiredness are the features  of  Pitha paandu. 
 
As  per  “Agasthiyar Vaithiya Rathna Surukkam” 
“உற்நத஡ார் அன்ணதத஡ம் அத஧ாசகம் உ஡஧஥ந்஡ம் 
ப௃ற்நி஦ ஥ார்புத஢ாய் ப௄த்஡ி஧ம்மதான்ணின் ஬ன்ள஥ 
ம஬ற்நி தசர்புநங்கால்ளக கண்஬ஙீ்குடல் ம஬ளுத்஡ல் த஬ர்த்஡ல் 
தற்நி ம஡ாக்கிற்காய் த஦ித்஡ி஦ தாண்டு஬ாத஥”  
-Agasthiyar Vaithiya Rathna Surukkam.
(22) 
 Indigestion, 
 Change of  taste, 
 Flatulence, 
 Chest tightness, yellowish discolouration of urine, 
 Oedema of  limbs,  
 Paleness of  skin, 
 Sweatness  are  the  features  of  Pitha paandu. 
“ஆணகண் ஥னசங்கள் அ஠ி஢கங் கறுப்த஡ாங் 
஡ாக஥ா ஥ங்கம஥ங்கும் ஡டி஦டி தடுளகததான 
கண஥ாய் ஢டுக்கப௃ண்டா ஬ிளசந்து துர்தனப௃ண்டாம்:”  
-  Agasthiyar Vaithiya Rathina Surukkam.
(22) 
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 Discolouration of conjunctiva, urine, faeces and nails, 
 Excessive thirst, 
 Pain in whole body,  lassitude, 
 Fatigue. 
In  “Agasthiyar Gunavaagadam” 
“உண்டாகும் த஬ளப ஡ன்ணில் த஡கத஢ர்ள஥ 
    உறு஡ி஦ாய் மசால்லுகிதநன் ஢ன்நாய் தாரு 
   குண்டாண ப௃கம்கண்கள் உ஡டு ஢ாக்கு 
    குநிப்தாண ஬ாய்த஬கும் த஡கப௃ற்றும் 
ம஬ண்டாக த஬ப௅னர்ந்து ம஬ண்ள஥஦ாகி 
   ஬ி஧ல் ஢கங்கள் ப௃ழு஬஡ிலும் இ஧த்஡ம் ஬ற்நி 
குண்டாண கால்கள்஡ாம் ஡஠ிந்து ஢ிற்கும் 
 கரு஬ாண ஢ாடி஦து ம஥து஬ாய் ததாத஥ 
ததாத஥஡ான் ஡ீதணங்கள் ஥ட்டுப்தட்டு 
   மதானி஬ாண கண்஬ி஫ிகள் மதருத்து த஡ான்றும் 
ஆத஥஡ான் அசக்஡ி஦ ஥ா஦ாசம் கண்டு 
   அ஬஧ளடப௅ம் ஡஬ிர்ந்து மதருப௄ச்சு கண்டு 
ப௄தட஡ான் ப௄ர்ச்ளசப௅டன் ஥ார்துடித்து 
   ப௃டி஬ாண கணுக்கானின் ஬கீ்கப௃ண்டாய் 
தூத஥஡ான் இரு஡஦த்஡ின் ஬஡ணந் ஡ன்ணிற் 
   துருந்து஡ிகள் சத்஡஥து தகட்கும் தாத஧”  
                                                                        -Agasthiyar Gunavaagadam.
(23) 
 Oedema of eyes, 
 Ulceration of tongue,  
 Pallor of nails, 
 Weak pulse, 
 Loss of appetite, 
 Dyspnoe on exertion, 
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 Tachychardia, 
 Oedema of ankle, 
 Cardiac murmurs occurs. 
 
As  per “Pathinen siddhargal naadi saasthiram”: 
                       “இரு஥லு ஥ிளபப்பும் ம஢ஞ்சில் திடி஦து ஥ிகவுண்டாம்  
                        ம஬குதன கிறுகிறுப்பு த஥ணிப௅ம் ம஬பிநிப் ததாகும் 
                         உருகி஦ தல்லும் ஢ாவு காய்ச்சலு஥ிளபப்பு ப௃ண்டாம் 
                         மதருகி தித்஡தாண்டு ம஦ன்ணத஬ ததசனாத஥”  (24)    
             
 Cough, dyspnoea  on  exertion,  
 Chest tightness,  
 Giddiness, 
 Pallor of skin, 
 Anorexia  are  the  features  of  Pitha paandu. 
In “Jeevaratchaamirtham” 
 Yellowish discolouration of urine and skin, 
 Lassitude,  loss of appetite, 
 Dryness  of  tongue, fatigue, 
 Palpitation.(25) 
NOI ENN: 
The types depending upon the classsifying authors,  
 According to “Yugi Vaithya Chinthamani” 
“கூநத஬ தாண்டு஬ிடப் மத஦ள஧க் தகபாய் 
  குநிப்தாக ஍ந்து஬ி஡ ஥ாகும் தாரு 
஬ா஧த஥ ஬ா஡஥ாம் தாண்டு த஬ாடு 
  ஥ார்க்க஥ாம் தித்஡த்஡ின் தாண்டு஬ாகும் 
த஡நத஬ சிதனட்டு஥஥ாம் தாண்டு ஡ாணாம் 
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  ஡ிரித஡ா஭ப் தாண்மடாடு ஬ி஭ப்தாண்டாகும் 
ஆநத஬ தாண்டு஬ிட ஬ாண்ள஥ ம஦ல்னாம் 
  ஆ஧ாய்ந்து மசால்னத஬ அநிந்து மகாள்தப”  
-Yugi Vaithiya Chinthaamani.
(26) 
 Vaadha Paandu 
 Pitha Paandu 
 Silethuma Paandu 
 Thirithosa Paandu 
 Visha Paandu 
According to " Agathiyar’s  Gunavagadam” 
“தா஧டா தாண்டு ஬ளக மசால்னக் தகபாய் 
  த஧஬ாண தாண்டது ஡ாணஞ் தச஦ாகும் 
஬ா஧ாடா ஬ி஬ா஡ தித்஡ம் சீ஡ தாண்டு 
  ஬ளக஦ாண ஬ிடதாண்டு ஥ிருத்஡ிகா தாண்டு” 
                                                               -Agathiyar Gunavagadam 
(27) 
 Vaadha Paandu 
 Pitha Paandu 
 Silethuma Paandu 
 Vida Paandu 
 Miruthiga Paandu 
According  to  “Dhanvanthiri Vaithyam” 
     “த஦ித்஡ி஦ தாண்டு ஬ா஡ தாண்டுத஬ சிதனத்து஥ தாண்டு  
      ஬ி஦த்஡ிரி த஡ாடப் தாண்டு ம஬ளும் தித்஡ சிதனத்து஥ தாண்டு  
      த஦ித்஡ி஦ ஬ா஡ தாண்டு தகற் சன்ணி஬ா஡ தாண்டு 
      ஢஦ப்புறும் தாண்டு த஬஫ின் கு஠த்ள஡ ஢ான் ஢஬ினலுற்தநணன்”     
          -Dhanvanthiri Vaithyam. (28)          
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 Vaadha Paandu 
 Pitha Paandu 
 Silethuma Paandu 
 Thirithoda Paandu 
 Pitha Vaadha Paandu 
 Pitha Silethuma Paandu 
 Sannivadha Paandu 
As  per  “Jeeva Rakshamirtham” 
 Vaadha Paandu 
 Pitha Paandu 
 Silethuma Paandu 
 Thirithosa Paandu 
 Nanju Paandu 
 Miruthiga Paandu 
 Alimuga Paandu(29) 
As  per “ Kandasamy Mudaliyar’s Vaidhiya Sara Sangiraham” 
 Vaadha Paandu  
 Pitha Paandu 
 Moola Paandu 
 Moola Pitha Paandu 
 Visha Paandu(30) 
As  per  “Seetharamprasath Anubava Vaithiya Ragasiyam” 
 Vaadha Paandu 
 Pitha Paandu 
 Silethuma Paandu 
 Thirithosa Paandu 
 Nanju Paandu(31) 
As  per “ Kannusami’s  Chikicha Rathina Deepam” 
 Vaadha Paandu 
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 Pitha Paandu 
 Silethuma Paandu 
 Vida Paandu 
 Paithiya Paandu(32) 
As  per  “Pararasa sekaram” 
 Vaadha Paandu 
 Pitha Paandu 
 Silethuma Paandu 
 Vida Paandu 
 Miruthiga Paandu(21) 
As  per “Agasthiyar Gunavaagadam” 
 Vaadha Paandu 
 Pitha Paandu 
 Silethuma Paandu 
 Vida Paandu 
 Miruthiga Paandu(27) 
As  per “Sarabendrar Vaithiya Muraigal” 
 Vaadha Paandu 
 Pitha Paandu 
 Silethuma Paandu 
 Sanni Paatha Paandu 
 Manthindrathaal Erpatta Paandu(33) 
MUKKUTRA VERUPAADUGAL 
As per Agasthiyar Gunavaagadam, Ranjaga pitham is responsible for 
production of blood and gives colour. Due to nutritional defect  Ranjaga pitham gets 
deranged and leads to Pitha paandu noi.
 (23) 
There will be loss of body strength with anorexia. The food ingested will not 
be digested properly. In view of  these there will be defective  hemopoiesis. Ranjaga 
pitham which impart colour to the skin also become hypovolemic and the pitha 
17 
 
thodam gets aggravate as a result the activities of other thodams gets affected 
adversely and aggravates the disease.  In addition, swelling of the body will also 
occur. 
(34) 
CURABLE AND INCURABLE DISEASES 
           Those types of  anaemias  where  uncontrolled vomiting or diarrhoea, excessive 
oedema of the body, excessive thirst, hiccup and cough  develop are cannot be easily 
cured. In addition, toxic anaemia is also not easily curable disease.
(35)  
NAADI NADAI 
Naadi   is  the  oldest  diagnostic  tool handled  by  siddhars. It  is divided into 
Vaadha , Pitha , and  Kapha . Its  normal  ratio  is  1:1/2:1/4.  Any variation in  these  
is  the  sign of diseases. 
        In   Azhal  veluppu  noi  two  types  naadi  are felt: 
 Pitha Vaadha Naadi 
 Kabha Pitha Naadi 
“சிநப்தாண தித்஡த்஡ில் ஬ா஡ ஢ாடி 
 தசரிலுறு ஡ாது஢ட்ட ப௃஡஧ தளீட 
உளநப்தாகச் மசரி஦ாள஥  குன்஥ஞ்சூளன 
 ப௅ற்ந சு஧ங்கி஧ா஠ி ஬஦ிற்நிள஧ச்சல் ஥ந்஡ம் 
 
அளநப்தாண ஓங்கா஧ புந஢ீர்க்தகாள஬ 
 ஆ஦ாச஥ி஧க்க ம஥ாடு஥஦க்க ப௄ர்ச்ளச 
ப௃ளநகாய்வு ஬ிட஬கீ்கம் ப௄ன஬ாய்வு 
 ப௃஧டாண த஢ாய் தனவுப௃டுகும் தண்தத”  
 
“இட஥ாண தசத்து஥த்஡ில் தித்஡ ஢ாடி 
  ஋ழுந்஡னுகில் ஬ிடப௃டதண ஬கீ்கப௃ண்டாம் 
஡ிட஥ாண குபிர்காய்ச்சல் ஥ஞ்சள் த஢ாவுந் 
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  த஡கத்஡ிலுளபச்சனிளபப் திரு஥ல் ஬ாந்஡ி 
 
஬ிட஥ாண ம஢ஞ்சளடப்பு சு஬ாசம் ஬ிக்கல் 
  ம஬குசு஧ப௃ம் ஢ா஬நட்சி தாண்டுத஧ாகம் 
அட஥ாண கு஬ளப஧த்஡ ஥஡ிசா஧ந்஡ான் 
  அணுகிம஬கு தனத஢ாய்க்கு ஡டங்கண்டாத஦ா” (36) 
 
“கு஡ித்஡ிடும் ஬ா஡஢ாடி கூடிடும் தித்஡த்த஡ாதட 
஡த்஡ித஦ ஢டக்கு஥ாகில் சரீ஧த஥ ம஥த்து஬ற்நி 
ம஥த்஡த஬ ஬ாய்஢ீம஧ாநி த஥ணிப௅ம் ம஬ளுத்துக்காணும் 
தித்஡தாண்டு த஧ாகம஥ன்று ததசிணார் சூ஡ாய்த்஡ாதண ” 
ASATHIYA KURIKUNANGAL: 
As  per  Kannusamiyam  the  oliguria  and  diarrhea  persist  in  Paandu Noi 
leads  to  delayed  prognosis. 
“தாண்டு தி஧த஥கம் தன்஬ா஡ சூளனகுன்஥ம் 
த஬ண்டா ச஦ஞ்சன்ணி ம஬ண்தசாள஬ ஢ீண்ட 
அ஡ி஢ீத஧ கா஥ாளன ஦ாணதி஠ி ஡ம்ப௃ள் 
அ஡ி சா஧஥ாகா ஡நி”(37)                    
Increased  sexual  desire and increased  intake of  pitha  foods  in paandu noi  
will  leads  to Kaamalai. 
“஬ிபம்தத஬ தாண்டு ப௃ற்நி஦ிருக்கும் ததாது 
஥ீநித஦ தித்஡ ஬ஸ்து஡ளணப் புசித்஡ால் 
புபம்தத஬ ஥ங்ளகப௅டன் பு஠ர்ச்சி மசய்஡ால் 
பூண்டிடுத஥ கா஥ாளன ம஦ன்னும் த஧ாகம்” (38) 
PINIYARI  MURAIMAI (DIAGNOSIS) 
Diagnosis  is  based upon  three  main principles. They are 
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 Poriyal Therthal 
 Pulanal Therthal 
 Vinaathal 
Findings  with  respect  to  Pitha  Paandu Noi 
Pori, Pulanaal therthal 
Mei: 
 Pallor  of  skin, Mild  yellowish discolouration of  skin, Koilonychia. 
Naa: 
 Pallor  of  tongue, Glossitis, Angular  stomatitis. 
Kan: 
 Pallor of conjunctiva 
ENVAGAI THERVUGAL: 
 Naa 
 Niram 
 Mozhi 
 Vizhi 
 Malam 
 Moothiram 
 Sparisam  
 
GENERAL FINDINGS: 
Naa: 
Size, movements,  colour, salivary secretion, inflammation, taste changes, 
deviation and  ulceration of  tongue  is  noted. 
 
 
20 
 
Niram: 
Colour  of  skin is  noted  if  any  pallor, cyanosis yellowish discolouration, 
oedema is noted. 
Mozhi: 
Whether any high pitched, low pitched or sound like any instruments character 
of speech is noted. 
Vizhi: 
Colour, eyeball movements, vision, lacrimation, ulceration  and paleness of 
lower eyelids  and discolouration  of  conjunctiva  are  noted. 
Malam: 
Colour, odour, consistency, bulk, nature of faeces 
Moothiram: 
Colour, odour, volume and froth are considered 
Sparisam: 
Temperature, pain  and  nature  of  skin  is  noted 
 
FINDINGS IN PITHA PAANDU NOI: 
Naa  -  pallor, bitter taste, glossitis, stomatitis 
Niram – the natural colour becomes pale or diminished 
Mozhi – normal pitch 
Vizhi – pallor of  conjunctiva , dimness of vision 
Malam – normal defaecation or constipation 
Sparisam – normal temperature, sometimes hypothermia, dry skin 
Naadi – pitha  vaatham or kapha pitham 
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Moothiram – sometimes  oliguria 
In  moothiram, neerkuri  and  neikuri  are  examined. 
 
Procedures for collecting urine samples 
“அருந்து ஥ாநி஧஡ப௃ம் அ஬ித஧ா஡ப௃஥஡ாய் 
அஃகல் அனர்஡ல் அகானஊண் ஡஬ிர்ந்஡஫ற் 
குற்நப஬ருந்஡ி உநங்கி ள஬களந 
ஆடிக்கனசத் ஡ா஬ித஦ காது மதய் 
ம஡ாருப௃கூர்த்஡க் களனக்குட் தடு஢ீரின் 
஢ிநக்குநி ம஢ய்க்குநி ஢ிரு஥ித்஡ற் கடதண”  
-Noi Nadal Noi Muthal Nadal Thirattu.
(39)
 
CHARACTERS OF URINE: 
It  has  got  five  main  characters 
 Niram – colour 
 Edai -    weight 
 Manam -  odour 
 Nurai – froth 
 Enjal – sediments 
 
ENJAL ILAKKANAM IN PAANDU NOI: 
Oliguria  of  unknown cause and oliguria  irrespective  of  increased intake of  
water paves  way  for  Paandu Noi 
NEIKURI: 
“஢ிநக்குநிக் குள஧த்஡ ஢ிரு஥ா஠ ஢ீரிற் 
சிநக்க ம஬ண்ம஠ய்த஦ார் சிறுதுபி ஢டு஬ிடுத் 
ம஡ன்றுநத் ஡ிநந்ம஡ானி ஌கா஡ள஥த்஡஡ி 
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ணின்ந஡ி஬ளன ததாம் ம஢நி஬ி஫ி஦நிவும் 
மசன்நது புகலுஞ் மசய்஡ிள஦ ப௅஠த஧” 
-Noi Nadal Noi Mudhal Nadal Thirattu.
(40) 
After collecting the sample urine in a bowl is placed in sunlight. Then a drop of 
oil is draped into it carefully without any shake. Note the shape of the spreading oil is 
observe 
“அ஧ம஬ண ஢ீண்டில் ஬ா஡ம் 
ஆ஫ிததால் தடரில் தித்஡ம் 
ப௃த்ம஡ாத்து ஢ிற்கில் ம஥ா஫ி஬ம஡ன் கதத஥” 
-Noi Nadal Noi Mudhal Nadal Thirattu.
(41) 
 
Vaatha disease – oil drop spreads out like a snake 
Pitha disease - oil drop spreading looks like ring shape 
Kabha disease- oil drop stays like pearl without spreading  
 
NEIKURI IN PAANDU NOI: 
The neikuri observed in paandu  noi  patients  shows ring like structure. 
Because the prime cause for disease is the increase in pitha kutram. 
UYIR THATHUGAL: 
Three vital forces are necessary  in proper ratio for the normal  functioning of  
body. They are 
1. Vaatham 
2. Pitham 
3. Kabham 
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VAATHAM: 
It  is divided into 10 types. Its normal function and its variations in pitha 
paandu noi  are described below as per in Siddha text. 
S.NO TYPES OF 
VAATHAM 
FUNCTIONS VARIATIONS IN 
DISEASE 
1. Piranan 
(Uyirkkaal) 
Responsible for function of 
respiratory system and for 
tissue nutrition 
Affected due to 
breathlessness or 
dyspnoea 
2. Abhanan 
(Kizhnokkukaal) 
Responsible for excretary 
system for normal 
evacuation of  bladder and 
bowels also concerned with 
Mensturation and 
ejaculation of sperm. 
Affected in case of 
constipation and 
Menorrhagia.  
3. Viyaanan 
(Paravukaal) 
Responsible for function of 
nervous system as neuro 
chemical transmission, 
innervations of organs and 
also for locomotor activity 
Affected because of 
pallor of skin. 
4. Uthaanan  
(Melnokkukaal)  
 
Responsible for reflexes 
such as cough, sneezing, 
vomiting and speech 
Affected because of 
nausea. 
5. Samaanan 
(Nadukkaal) 
Essential for proper 
digestion,assimilation and 
carries the digested nutrients 
to each and every organ.  
Affected because of loss 
of appetite and anorexia. 
6. Naagan Responsible for higher 
intellectual functions, 
opening and closure of eyes. 
Generally not affected 
7. Koorman It acts through facial nerve, 
responsible for opening and 
closing of  eyes, normal 
Affected because of  
dullness of vision 
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vision, yawning and lacrimal 
secretion 
8. Kirukaran It produces nasal and 
salivary secretions, 
stimulates appetite, sneezing 
and cough. 
Affected in cases of loss 
of appetite 
9. Devadhathan Responsible for malaise, 
fatiguability and asthenia, 
emotions, anxiety and 
depression 
Affected in case of 
insomnia 
10. Dhananjeyan Resides in the cranium and 
produces bloating of the 
body after death. This leaves 
from the body after 3 days 
of death, forming a way 
through the skull.
(42) 
 
 
- 
 
PITHAM: 
S.NO VARIETIES SITUATION FUNCTION  VARIATION 
IN DISEASE 
1. Paasagam(Anilapitham) Between 
stomach  and 
intestine 
It gives 
appetite and 
helps digestion 
Affected 
because of loss 
of appetite and 
anorexia. 
2. Ranjagam Stomach It is 
responsible for 
RBC formation 
and gives red 
colour to blood  
Affected 
because of 
paleness 
3. Saathagam Heart  Controls 
whole body 
Affected 
because of 
difficulty in 
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working 
4. Aalosagam Eyes Brightens eye 
faculty of 
vision 
Affected 
because of 
dimness of 
vision 
5. Praasagam Skin Gives 
complexion to 
skin.
 (43)
 
Affected 
because of 
pallor and 
dryness 
 
KABHAM:  
S.NO VARIETIES SITUATION FUNCTION VARIATIONS 
1 Avalambagam Lungs It helps in 
functioning of 
other kabhams and 
pumping heart. 
Affected because 
of dyspnoea on 
exertion. 
2. Kilaethagam Stomach It moistens food 
stuffs and helps in 
digestion 
Affected because 
of indigestion 
3. Pothagam Tongue Helps to recognize 
taste 
Affected because 
of bitter taste in 
tongue 
4. Tharpagam Head Gives cooling 
sensation to body 
Normal 
5. Santhigam Joints Helps in movement 
of joints by 
providing 
lubrication.
(44)
 
Normal 
 
 
UDAL THATHUKAL: 
1.Saaram 
2. Senneer 
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3. Oon 
4. Kozhuppu 
5. Enbu 
6. Moolai 
7. Sukkilam /Suronitham 
 
These  are the  seven udal  thathukal  elements  building  the human 
body whose normal function is essential for our well being. Any deviation in 
these leads to pathological conditions. 
S.NO THATHUKAL CHARACTERS   VARIATIONS 
 1. Saaram It gets separated from food 
and nourishes the body 
Affected because of  anorexia 
and indigestion 
2. Senneer Responsible for existence 
of knowledge, strength, 
glory and blood 
component. 
Affected because of pallor of 
skin and conjunctiva 
 3. Oon Moulding the shape of the 
body and muscles. 
Affected because of  anorexia 
and malabsorption. 
 4.  Kozhuppu  Acts as lubrication for the 
functioning of organs and 
provides  a  cover for the 
body. 
Generally not affected 
5. Enbu Structural unit  of  body 
and responsible for shape 
of  body. 
Generally not affected 
6. Moolai It represents the bone 
marrow and strengthens 
the bone. 
Generally not affected 
7. Sukkilam/suronitham Helps  in reproduction.
(45)
   Affected because of 
Amenorrhoea / 
Menorrhagia 
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KAALAM: 
It refers to the position of the sun in the year is divided into six seasons. 
 S.NO  POZHUTHUGAL     MUKKUTRA 
VERUPAADUGAL 
  1.  Kaar kaalam ( mid -avani & mid- 
puratasi) 
Vatham - Vetrunilai valarchi 
Pitham  - Thannilai valarchi 
  2. Koothir kaalam (mid-iypasi & mid- 
karthigai) 
Vatham  -  Thannilai valarchi 
Pitham - Vetrunilai valarchi 
   3. Munpani kaalam (mid-margazhi & 
mid- thai) 
Pitham - Thannilai valarchi 
   4.  Pinpani kaalam (mid-maasi & mid- 
panguni) 
Kabham- Thannilai valarchi 
   5. Elavenil kaalam (mid-chithirai & 
mid-vaikaasi) 
Kabham - Vetrunilai valarchi 
   6. Mudhuvenil kaalam (mid- aani & 
mid- aadi) 
Vatham - Thannilai valarchi.
(46)
 
 
RELATION BETWEEN MUKKUTRAM, KAALANGAL AND THINAIGAL: 
 Mukkutram Thannilai vazharchi 
(accumulation) 
Vetrunilai 
vazharchi 
(aggravation) 
Thannilai 
adaithal 
(alleviation) 
Thinai 
VATHAM Muthuvenil kaalam Kaar kaalam Koothir kaalam Neithal 
PITHAM Kaar kaalam Koothir kaalam  Munpani kaalam Mullai 
KABHAM Pinpanikaalam Elavenilkaalam Mudhuvenil 
kaalam 
Kurinji 
 
VERUPADUTHI KANITHAL (DIFFERENTIAL DIAGNOSIS): 
The following conditions  are  taken into  account for  arriving  at final 
diagnosis  of  pitha  paandu noi  with the symptoms  manifested  in  the  respective 
conditions. 
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VAADHA PAANDU NOI: 
SIGNS AND SYMPTOMS: 
 Lower abdominal colic pain 
 Thirst 
 Anorexia 
 Dryness of skin 
 Constipation 
 Rigor 
 Pallor of body. 
 
IYA PAANDU NOI 
SIGNS AND SYMPTOMS 
 Pallor of skin 
 Salty taste of tongue 
 Vomiting 
 Sneezing 
 Hoarseness of voice  
 Cough 
 Fatigue 
 Oligospermia 
NANJU PAANDU NOI: 
SIGNS AND SYMPTOMS: 
 Pallor of body 
 Thirst 
 Loss of taste 
 Dyspnoea 
 Anorexia 
 Vomiting 
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DIET: 
 Easily digestable food with Iron content is preferred. 
 Karisalai, Ponnanaganni, Sirukeerai, Araikeerai, Murungai keerai. 
 Kathiripinju, Avarai pinju, Murungai pinju, Vazhai katchal 
 In severe cases with anorexia and indigestion only kanji and soups are advised. 
 Easily digestible foods such as rice gruel and soups should be given. 
 To improve general health Kaadai, Gowthari, Udumbu, Vellatukari are 
included in diet. 
 Regular  intake  of  Dates, Fig , Citrus fruits  like orange is must. 
 Liver of  Goat, its bone and stomach, Fish  and Egg yolk can be given. 
 Wheat, Green leafy vegetables and Oats are rich in iron. 
 Soups  of  bones  and meat  is advised. 
 In case of  oedema  Neermulli keerai, Vazhai thandu can be given. 
 
PATHIYAM: 
The food which is sour and bitter taste should be strictly avoided. 
 Agathi 
 Pagal 
 Pugaiyilai 
Madhu  should  be  avoided  during  the treatment. 
 
 
 
 
 
 
MODERN ASPECT 
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                                       MODERN ASPECT     
BLOOD:  
   Blood  is a connective tissue  in  fliud  form. It  is  called  “fluid of health”  due to 
protection  of  body against  the  diseases and get  rid of  the  waste  products  and  
unwanted substances by transporting  them  to  the excretory organs  like  kidneys. 
The blood  is  a  specialized  body fluid that  supplies  essential  substances  and  
nutrients  like  sugar, oxygen and  hormones  to  the  cells. Blood  is  five  times  more  
viscous  than  water  due  to  red  blood cells  and   plasma proteins.
(47)
 
COMPOSITON  OF  BLOOD: 
     Blood  consists  of  a  solid   portion and  a  fluid portion. The  solid  portion  
constitutes  the  blood  cells  called  red  blood cells, white blood cells   and  platelets  
and  the  fluid  portion  is  the plasma. The plasma  contains  90%  water  and 10% 
solids . Blood makes up about 8% of the human body weight .The  normal  blood  is  
slightly alkaline  in reaction. The  pH  of  blood  is 7.3 or 7.4 due  to  the  presence of  
bicarbonates  and  alkaline phosphates. The  pH  of  blood  is  regulated  by buffer  
systems  in  the  blood, renal  mechanisms  and  respiratory mechanism. 
FUNCTIONS  OF BLOOD: 
Transport of nutrients, waste products, blood and respiratory gases  
 Immune function. 
 Storage function. 
 Regulation of water balance. 
 To maintain homeostasis of water, ions or Ph. 
 Transport of Hormones and Enzymes. 
 Distribution  of  heat throughout the body. 
 Blood clotting. 
 Temperature regulation. 
 Communication- hormones distributed to all part of the body. 
 Defensive function. 
 Regulates blood pressure. 
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ERYTHROCYTES OR RED BLOOD CORPUSCLES: 
       RBC or Erythrocytes form one of  the  important constituent  of  the  blood. The 
cytoplasm of the RBC contains special pigmented  protein  called haemoglobin (Hb) 
which forms 90% of the weight of erythrocytes. Red cells are biconcave discs having  
a mean diameter of about 7.8 micrometers and thickness of  2.5 micrometer. The 
average volume of the red  blood  cell  is 90 to 95 cubic micrometers. 
      Normal range of red blood cell count in 
          Adult Males -  5 millions/cu. mm of blood.  
         Adult Females -  4.5 millions/cu.mm of blood. 
                                                                                                                               
ERYTHROPOIESIS: 
    The process of formation of  RBC  is called Erythropoiesis. The formation of red 
blood cells  from stem cells in bone marrow regulated by the hormone erythropoietin 
from the kidneys. It is  stimulated  by  decreased  oxygen  in  circulation,  regulated  
by  the   hormone erythropoietin  responsible  for  erythropoiesis. 
SITES OF RBC PRODUCTION: 
    Early weeks of embryonic life - Nucleated  RBCs- Yolk sac . 
    Middle  trimester  of  gestation -  Liver  form  blood  cells 
    Last month  of  gestation  and  after  birth -  Red bone marrow  
    Most  RBCs  continue  to  be  produced  in  the  marrow  of  the  membranous  
bones ,such as-  Vertebra, Sternum  and  Ribs. 
GENESIS  OF  BLOOD  CELLS: 
         In  the  bone  marrow  are  cells  called  pluripotentialhemopoietic  stem  
cells,from  which  all  the  cells  in  the  circulating  blood  are  derived .The  
successive  divisions  of  the  pluripotential  cells   to  form  the  different  peripheral  
blood  cells. As  these  cells  reproduce,  continuing   throughout   the  life   of  the  
person, a  portion   of  them  remains  exactly  like  the   original  pluripotential  cells   
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and  is retained  in  the  bone  marrow  to  maintain  a supply  of  these,  although  their   
numbers  do  diminish  with  the age.  The larger  portion  of  the  reproduce  stem  
cells, differentiate   to   form   the  other  cells. The  early  offspring  still  cannot  be  
recognized   as  different  from  the  pluripotential   stem  cells, they   have  already  
become   committed  to  a  particular  line  of  cells  and   are  called  committed  stem  
cells. 
          The  different   committed  stem  cells, when  grown   in   culture,  will  produce   
colonies   of   specific  types   of  blood  cells.  A   committed  stem  cell  that  
produces  erythrocytes  is  called  a  colony-forming  unit- erythrocyte,  CFU-E is  
used  to  designate  this  type  of  stem cell. The  colony- forming  units  that  form  
granulocytes  and  moncytes  have  the  designation   CFU-GM. 
          Growth  and  reproduction  of  the  different   stem  cells are  controlled   by  
multiple  proteins  called  growth  inducers.  Four  types   of  major   growth  inducers.  
One  of  these,  interleukin-3, promotes  growth  and  reproduction  of  all the  different   
types  of  stem  cells. 
             The  growth  inducers   promote  growth   but  not  differentiation  of  the  
cells. This  is  the  function  of  another   set  of  proteins  called  differentiation  
inducers. Each  of  these  cause  one  type  of  stem  cell  to  differentiate  one  or  more  
steps  toward  a  final  type  of  adult  blood  cell. 
              Formation  of  the  growth  inducers  and  differentiation  inducers  is  
controlled   by  factors  outside  the  bone  marrow. In  the  case  of  red  blood  cells, 
exposure  of   the  body  to  low  oxygen  for  a  long  period  results  in  growth  
induction,  differentiation  and  production   of  greatly  increased  numbers  of  
erythrocytes.
(48) 
REQUIREMENTS FOR ERYTHROPOIESIS: 
1.Metals -  Cobalt and Manganese are required  for  red  cell  production. 
2.Vitamins - Vitamin  B12  and Folate  are  essential  for bio-synthesis of nucleic acid.   
 Vitamin C, Riboflavin, Pyridoxine, Vitamin E are necessary for synthesis of red cells.  
3. Aminoacids - Aminoacids comprise the globin component of haemoglobin. 
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4.Hormones - Erythropoietin plays a significant role in erythropoietic activity.   
Androgens  and  Thyroxine  plays  an  vital  role  in  red  cell  production. 
 
STAGES OF ERYTHROPOIESIS: 
         The red cells precursors are derived from pluripotent stem cells by a 
differentiation step. The  first colonies to appear are small and consist of about 8- 16 
cells, they are usually fully developed after a few days of incubation.  After  a longer 
period  in culture large colonies or bursts appear  the  cells which give rise to the small 
colonies are called CFU-E (colony forming units, erythroid) and those which produce 
the „burst‟ are called erythropoietin – dependent burst forming units or  BFU-E.   
        In early foetus  this process takes place in the mesodermal cells of yolk sac. By  
3
rd 
- 4
th
 month it moves to liver. After 7 month it occurs in bone marrow. 
Erythropoiesis takes 4 days.
 
        It consists of 7 stages: 
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STAGES  OF  ERYTHROPOIESIS 
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1. Proerythroblasts. 
2. Basophilic erythroblasts (early normoblast) - haemoglobin synthesis begins in this 
stage. 
3. Polychromatophil erythroblast (intermediate normoblast). 
4. Orthochromatic erythroblast (late normoblast). 
5. Erythrocytes. 
6. Reticulocyte -  A  small number  of  reticulocytes  are found  in circulation. 
7. Mature erythrocyte - There  is  lose  of  ribosomes   in  the  final  stage  of  
maturation  and these cells  enter  the  circulation. 
FACTORS NECESSARY FOR ERYTHROPOIESIS: 
1. General factors 
2. Maturation factors 
3. Factors  necessary  for  haemoglobin  formation 
GENERAL FACTORS: 
 Erythropoietin: 
     It  is the most important general  factor  for  Erythropoiesis. This  is  otherwise  
called  Haemopoietin or Erythrocyte stimulating factor. 
Source of secretion: 
    Erythropoietin  is  secreted  by  peritubular  capillaries  of  kidney. 
Stimulant for Secretion: 
   Hypoxia  is  the  stimulant  for  the  secretion  of  erythropoietin. 
Actions of Erythropoietin: 
   Erythropoietin causes formation and release of new RBCs into circulation. After  
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   secretion , it takes  about  4 to 5  days to show  the  action. 
   1.Production  of  Proerytroblasts from stem cells in CFU-E   of  bone marrow. 
   2.Development of  Proerytroblasts  into matured RBCs. 
   3. Enter  of  matured Erythrocytes into blood. 
Thyroxine : 
       General metabolic hormone thyroxine  accelerates the process of  Erythropoiesis  
at many levels. 
Haemopoietic Growth  Factors: 
       Interleukins are the growth factors. Interleukins induce the proliferation of 
pluripotent stem cells. 
 Vitamins: 
      Vitamin B,C,D,E are necessary for Erythropoiesis. 
MATURATION FACTORS: 
1.Vitamin B12: 
             This  is otherwise called Extrinsic factor. It  is  essential  for  synthesis  of  
DNA. Deficiency of  Vit –B12 leads  to  failure  in  the  maturation   of  the cell  and  
reduction  in the cell division. Cells  are  larger  with  fragile  and  weak  cell  
membrane. Deficiency  causes  Pernicious anaemia. 
2.Intrinsic factor of Castle: 
              It is produced in gastric mucosa and it is essential for the absorption of Vit-
B12 from the intestine. In  the absence of  Intrinsic factor, Vit-B12  is  not  absorbed  
from  the  intestine. Deficiency of Intrinsic castle leads to Pernicious anaemia. 
3. Folic acid: 
              Folic acid  is essential for maturation. It is required for the synthesis for DNA. 
In the absence of Folic acid, the synthesis of DNA decreases causing maturation 
failure. This  leads to anaemia  in  which the cells  are larger  and appear  in  
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Megaloblastic (proerythroblastic) stage and  anaemia  due to  Folic acid  deficiency  is 
called  Megaloblastic anaemia .(49) 
FUNCTIONS OF RBC: 
   1.RBC carry O2  and CO2 
   2.Maintaining acid balance of body and ionic equilibrium 
   3.Bile pigments formed from Hb are destroyed RBCs 
DESTRUCTION OF RBC: 
      Red cells have a mean life span of 120 days, after  which  red cell metabolism  
gradually deteriorates  as  the enzymes are not replaced. The destroyed red cells are 
removed  mainly by the macrophages of  the reticulo endothelial system of the 
marrow, and  to some extent by the macrophages  in the  liver  and  spleen. The  
breakdown  of  the  red  cell liberates  iron  for recirculation via plasma transferring  to  
marrow erythroblasts, and  protoporphyrin is broken down to bilrubin.  Bilrubin  
circulates  to  the liver  where  it  is  conjugated  to its diglucuronide  which  is 
excreted  in  the  gut  via bile  and  converted  to  sterocobilinogen  and  stercobilin 
excreted  in  the  faeces. Part  of  sterocoblinogen  and  stercobilin  is  reabsorbed  and  
excreted  in  the urine  as  urobilinogen  and  urobilin.
 (50) 
HAEMOGLOBIN: 
        Haemoglobin consists of a basic protein, globin and  the  iron-porphyrin  
complex, Haem. The molecular weight  of  Haemoglobin  is  68000. Normal  adult  
haemoglobin  consistutes  96-98% of total haemoglobin  content  and consists  of  four  
polypeptide chains. Most of the haemoglobin (65%) is synthesized by the nucleated 
red cell  precursors  in the marrow, while the remainder (35%) is  synthesized  at the 
reticulocyte stage. Synthesis of haem occurs largely in the Mitochondria. 
Protoporphyrin  combines  with   iron  supplied  from  the circulating  transferring  to  
form heam. Each molecule  of  haem  combines  with  a  globin chain synthesized  by 
polyribosomes . A tetramer  of  four  global  chains  constitutes the haemogoblin  
molecules. 
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IRON  
      It is present in Ferrous (fe++)  form. It is unstable or loose form, under  certain  
conditions, the iron may be present  in Ferric state (fe+++) which  is  stable form. 
PHORPHYRIN: 
     The  pigment  part  of  heme  is  called   porphyrin. It is formed  by  four pyrole 
rings. The pyrole rings  are  attached  to  one  another  by  methane bridges. The  iron  
is  attached to ” N‟ of each pyrole ring  and N of globin molecule. 
GLOBIN: 
      It  contains  four  poypeptide chains. Among the four polypeptide chains two  are  
alpa chains  and  two  are  betachains. 
SYNTHESIS  OF HAEMOGLOBIN:  
       Synthesis  of  haemoglobin actually  starts  in  pro-erythroblastic stage. It appears 
in the intermediate normoblastic  stage  only. Production  of  haemoglobin  is 
continued until the stage of reticulocyte. Haem portion is  synthesied  in  Mitochondria  
and  protein  part  globin  in  Ribosomes. 
TYPES OF HAEMOGLOBIN: 
        Haemoglobin can be broadly divided into normal and abnormal types. 
Normal haemoglobins 
    1. Adult haemoglobin  - Hb A 
    2. Fetal  haemoglobin - Hb F (Major Hb in intrauterine life). 
    3. Embryonic  haemoglobin - These are confined to the very early embryonic stages 
       of  development. 
 FACTORS NECESSARY FOR HAEMOGLOBIN FORMATION 
        Various materials  are  essential  for the formation of haemoglobin in  the RBCs. 
Deficiency  of  these substances  decreases  the production of  haemoglobin  leading  
to  anaemia  such  factors  are  
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     1. First  class  proteins  and  aminoacids - Proteins of high biological value are   
essential for the formation of  haemoglobin. 
     2. Iron - Necessary for the formation of  haem  part of the haemoglobin. 
     3. Copper - Necessary for the formation  of  haem  part of the haemoglobin. 
     4. Cobalt and  Nickel - Necessary for the utilization  of  iron during haemoglobin  
formation. 
     5. Vitamins - Vitamin C, Riboflavin, Nicotinic acid and Pyridoxine are essential 
for the formation of  Haemoglobin. 
ABNORMAL HAEMOGLOBIN DERIVATIVES: 
           It is formed by carbon monoxide poisoning or due to some drugs like nitrates 
and sulphonamides. 
 Carboxyhemoglobin 
 Methemoglobin 
 Sulfhemoglobin(51) 
DESTRUCTION OF HAEMOGLOBIN: 
       After  the  lifespan  of  120 days, the  RBC  is destroyed  in  the  reticulo  
endothelial system, particularly  in  spleen  and  the haemoglobin  is  released   into  
the  plasma.  Haemoglobin  degraded  in  the reticulo  endothelial  cells  and  split  into  
globin and  haem.  Globin  is  utilized  for  resynthesis  of  haemoglobin.  Haem  is  
degraded  into  Iron and  porphyrin.  Iron  is  stored  in the body  as  Ferritin.   
HAEMOGLOBIN CONCENTRATION: 
        At  birth  HB concentration is about 33gm% by the end of the 3
rd
 month, it will 
fall to below normal 10.5gm% then gradually it will brought up at the end of 1 yr HB 
content will be 12.5gm%. 
The mean corpuscular HB content  is 29 micro gram.  
The MCHC% is about 35%. 
Colour index = % of HB/% of RBC. 
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Hb content in blood is estimated by haemoglobinometer. 
BLOOD INDICES: 
       The values of haemoglobin, PCV and total RBC count are used to calculate  red  
cell volume and red cell haemoglobin content and concentration are called red blood 
cell indices. The commonly estimated blood indices are  
    1.Mean cell volume (MCV). 
    2.Mean cell haemoglobin (MCH). 
    3.Mean cell haemoglobin concentration (MCHC). 
ABSOLUTE CORPUSCULAR VALUES: 
1. Mean corpuscular volume (MCV) is the average volume of each RBC 
expressed in cubic microns. 
   MCV= vol. of erythrocytes in cc in 1000cc of blood  
               RBC count per cmm in millions 
               = 450/5 = 90 cubic microns (80-94). 
2. Mean corpuscular haemoglobin content (MCH) is the average volume of 
haemoglobin in gram and volume of RBC in cubic microns. 
   MCH= haemoglobin in gram in 1000 cc of blood 
                              Volume of RBC in cubic microns 
                          =150/5 = 30 micro micro gram (30- 38) 
3. Mean corpuscular haemoglobin concentration (MCHC)% is the amount of 
haemoglobin in 100cc of RBc expressed in %. 
          MCHC= haemoglobin in gram in 100 cc of blood ×100 
                              PCV in 100 cc of blood 
                      =15×100/40 =1500/40=37.4% (30-38) 
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NORMAL VOLUME OF BLOOD INDICES: 
Normal PCV : 
     In males:  40 to 45% 
     In  females: 38 to 42% 
Normal MCV: 78 to 90 cu. micron 
Normal MCH: 27 to 32 pg 
Normal MCHC: 30 to 38% 
FUNCTIONS OF HB: 
1.Transport  of  O2  from lungs  to  tissues 
2.Transport  of CO2 from tissues to lungs 
3.Maintain  acid  base balance 
4.Source  of  bilirubin. 
ABNORMAL HAEMOGLOBIN DERIVATIVES: 
           It  is  formed  by carbon monoxide poisoning or due to some drugs like nitrates 
and sulphonamides. 
 Carboxyhemoglobin 
 Methemoglobin 
 Sulfhemoglobin 
FATE OF HAEMOGLOBIN: 
            The haemoglobin released  from  the cells  when  they   burst   is  phagocytized 
almost   immediately  by  microphages   in   many   parts  of  the  body  but   especially  
in   the  liver,  spleen  and  bone  marrow. During   the   next  few   hours   to  days, the  
macrophages   release   the   iron   from   the   haemoglobin   back   into  the   blood  to  
be   carried  by  transferrin  to  the   bone  marrow  for  production   of  new  red  blood   
cells  or  to  the liver   and  other  tissues   for   storage  in  the  form  of  Ferritin.  
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Theporphyrin   portion  of  the  haemoglobin   molecule   is   converted  by  the  
macropages,  through   a  series  of  stages, into  bile   pigment   bilirubin. 
IRON METABOLISM: 
       Iron is an essential mineral  and  important component of protein,  involved in 
oxygen transport. Iron is important for the formation of  haemoglobin  and  
myoglobin. It  is  also necessary for the formation  of  other substances  like 
cytochrome, cytochrome oxidase, peroxidise  and  catalase. The main functions  of  
iron are, 
        1. Transport of oxygen to the tissues 
        2. Participation in cellular oxidation mechanism 
ABSORPTION OF IRON: 
        Iron is absorbed mainly from the small intestine. Bile  is essential  for the 
absorption of iron.  Iron  is  present mostly in Ferric (Fe3) form. It is converted into 
ferrous form which is absorbed into the blood. Soluble ferric iron is converted  into 
ferric  iron  by the enzyme ferric reductase in the presence of hydrochloric  acid. In  
the  blood  ferric  iron  is  converted  into ferrous iron  and  transported. A peculiar 
feature of  Iron metabolism  is  that, only  a small part of the dietary iron is absorbed 
under normal conditions because the body has the limited capacity to excrete iron. 
TRANSPORT OF IRON: 
       Iron combines with  a beta globulin called apotransferrin resulting in the 
formation of  transferrin and iron is transported  in the form of transferring. 
Transferrin is the main form in which iron is transported  in the blood and iron in 
transferring  is in the ferric form. Iron combines with globin and released easily at any 
region in the body. Ferritin is the chief storage form of iron and is present in 
gastrointestinal mucosa, bone marrow, liver and spleen.
(52) 
DAILY REQUIREMENT OF IRON: 
Adult  male   :  0.5-1mg 
Adult  female  : 1-2mg   
 Infants   : 60µg/kg 
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Children  :  25µg/kg 
 Pregnancy  women: 3 – 5mg 
Iron  requirement(mg)=4.4× body  weight× Hb  deficit 
DAILY LOSS OF IRON: 
In males about 1mg of iron is excreted through faeces. In females amount of 
iron loss  is very  high due to menstruation. In  females, during  every  menstrual 
cycle, about 50 ml of  blood is lost  by which 25 mg of iron is lost. 
 
ANAEMIA 
       Anaemia is defined as a condition in which haemoglobin  level  is  below the 
normal range for patients age and  sex. According  to  WHO  Anaemia  is  a condition  
in which the number of red blood cells or their oxygen-carrying capacity is insufficient 
to meet physiologic needs, which vary by sex, age, altitude, smoking. In general, 
reduction of haemoglobin is associated with fall in erythrocyte count and packed cell 
volume.  Iron, Vitamin B12 and Folic acid  are the three main deficiencies that cause 
anaemia.  
       Anaemia is derived from the Greek word means “lack of blood”. It is the most 
common nutritional deficiency in the world. It occurs when the red blood cells do not 
carry enough oxygen to the tissues of the body due to 
 Decreased production of RBC. 
 Increased destruction of RBC. 
 Excess loss of blood from the body. 
     For Adults normal haemoglobin ranges (Males) - 13.0 g/dl 
            Females - 11.5 g/dl 
       Anaemia can be caused by the defective production of red cells  or an increased 
rate of loss of cells, either by bleeding or premature destruction (haemolysis). 
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 The causes of defective production of red cells include 
1) Deficiency of  Iron, Vitamin B12 or Folate. 
2) Anaemia of chronic disorders. 
3) Reduced erythropoietin production - chronic kidney disease. 
4) Primary diseases of bone marrow. 
      
CAUSES OF ANAEMIA: 
 1. Inadequate supply of nutrients resulting in deficiency of anaemias  (iron ,vitamins 
and proteins deficiency). 
 2. Aplasia of bone marrow. 
 3. Anaemia associated with chronic diseases. 
 4. Anaemia associated with renal failure. 
 5. Anaemia due to inherited diseases. 
 6. Anaemia due to blood loss. 
                       
 
 
 
                                         
 
 
 
 
 
45 
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MAIN FACTORS: 
The haemoglobin level at which symptoms and signs of anaemia develop depends 
upon 4 main factors. 
  1.The speed of onset of anaemia 
  2.The severity of anaemia 
  3.The age of the patient 
  4.The haemoglobin dissociation curve. 
SIGNS: 
1. Pallor of face, mucous membranes, conjunctiva and skin. 
2. Cardio vascular system - Tachycardia, cardiomegaly, dysnoea on exertion, 
congestive heart failure. 
3. Central nervous system - Faintness, giddiness, headache, tinnitus, drowsiness, 
numbness and  tingling sensations of the hands and feet. 
4. Reproductive system  -  Menstrual  disturbances  such  as  Amenorrhoea, 
Menorrhagia  and  loss  of  libido. 
5. Renal system - Mild proteinuria and impaired concentrating capacity of the kidney 
occur in severe anaemia. 
6. Gastro intestinal system - Anorexia, flatulence, nausea, constipation and  
weight loss.
(53) 
CLASSIFICATION OF ANAEMIA: 
1. Anaemia due to blood loss 
 Acute blood loss 
 Chronic blood loss 
2. Anaemia due to impaired cell formation. 
3. Anaemia due to increased red cell destruction. 
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Based   on  the  red cell size, haemoglobin content  and  red cell  indices, anaemias  are 
classified  into 3 types 
    1. Microcytic, hypochromic: MCV, MCH, MCHC are all reduced. 
    2. Normocytic, normochromic: MCV, MCH, MCHC are all normal. 
e.g. In acute blood loss, haemolytic anaemias, anaemia of chronic disorders 
    3. Macrocytic  anaemia: MCV is raised. 
e.g. In megaloblastic anaemia due to vitamin B12 or folic acid. 
Based on etiology, anaemia is divided into five types 
    1. Haemolytic anaemia. 
    2. Haemorrhagic anaemia. 
    3. Nutrition deficiency anaemia. 
    4. Aplastic  anaemia. 
    5. Anaemia of chronic diseases.
(54) 
IRON DEFICIENCY ANAEMIA: 
      The most commonest nutritional deficiency disorder throughout the world is Iron 
deficiency anaemia. It develops when the supply of iron is inadequate for the 
requirement of haemoglobin  synthesis. The development of Iron deficiency depends 
upon the following factors: 
     1. Increased blood loss 
     2. Increased requirements 
     3. Inadequate dietary intake 
     4. Decreased intestinal absorption. 
         Hypochromic anaemia due to iron deficiency is the commonest cause of anaemia 
throughout the world. It is estimated that about 20% of women in child bearing age 
group are anaemic and in adult males is about 2%. In this type all the three red cell 
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indices (MCV, MCH and MCHC) are reduced and occurs due to defective 
haemoglobin synthesis. Hypochromic anaemias are classified into two groups. 
         1. Hypochromic anaemia due to iron deficiency. 
         2. Hypochromic anaemia other than iron deficiency. 
ETIOLOGY: 
           1) Increased  physiological requirements: 
a) Growth – iron deficiency anaemia. 
b) Menstruation – anaemia common in adult menstruating women 
c) Preganancy – in pregnancy it is common in world wide. 
          2) Pathological blood  loss: 
a)  Mennorhagia – also antepartum and post partum bleeding. 
b) GI tract : 
 Bleeding piles 
 Aspirin , Indomethacin, Butazolidin and Corticosteroids 
 Peptic ulcers 
 Haemorrhoids 
 Carcinoma of stomach 
 Oesophagial varices 
 Ulcerative colitis 
 Hiatus hernia 
 Gastro-intestinal surgery 
 Intestinal infection and infestations – Ankylostomiasis, 
Amoebic or Bacillary infection. 
c) Urinary tract: 
 Recurrent haematuria 
 Haemoglobinuria 
d) Miscellaneous: 
 Cirrhosis of liver,  
 Hiasutus hernia 
 Crohn‟s disease 
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 Bleeding from gums 
 Ulcerative colitis 
e) Other causes: 
   Regular blood donation 
   Injuries and accidents 
   Recurrent epistaxis 
   Recurrent haemoptysis 
   Idiopathic pulmonary haemosiderosis 
3) Nutritional defect: 
 Low intake of  Iron rich diet 
 Poverty inhibitors in diet 
       4) Poor absorption of iron: 
 Achlorhydria 
 Gastrectomy 
 Coelic syndrome 
 Geophagia(55) 
 
CLINICAL FEATURES OF IRON DEFICIENCY ANAEMIA: 
 Weakness 
 Tachycardia 
 Increased basal  metabolic rate 
 Fatigue 
 Dyspnoea on exertion 
 Dizziness  
 Drowsiness 
 Palpitation 
 Pallor of skin, mucous membranes and sclera 
 Loss of appetite 
 Hair loss 
 Fainting  
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 Pruritis  
 Insomnia 
 Dysphagia 
 Menorrhagia 
 Koiloncyhia (spoon shaped nails) 
 Atropic glossitis 
 Angular stomatitis 
 Angina and congestive cardiac failure in older patients 
 Plummer-Vinson syndrome 
 Hepatosplenomegaly 
 Pica.(56) 
INVESTIGATIONS: 
                       1.  Blood count –  
       RBC count 
       Haemoglobin and haemocrit  are decreased 
       MCV, MCH and MCHC are decreased. 
 2.   Blood film –  
  Peripheral Smear shows hypochromia 
  Red cells are smaller in size. 
 3.  Morphological changes-  
 Anisopoikilocytosis 
 Elongated „pencil‟ cells , occasional polychromasia. 
 Hypochromic Microcystic and Normochromic Macrocystic 
 Red cell survival – decreased 
 Serum iron – decreased 
 TIBC – decreased 
 Serum Feritin concentration – levels of 10 mcg/1 or less in 
simple Iron deficiency anaemia. 
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 Bone marrow – Increased cellularity from increased 
haemopoietic   activity. Absence or reduction  in  Iron granules in RE 
cells of  the marrow. 
 
TO DETERMINE THE CAUSE OF IRON DEFICIENCY ANAEMIA: 
 STOOL EXAMINATION: 
                    Occult Blood – negative test do not exclude intermittent bleeding or 
bleeding  in the GI tract 
 Bulky,  Fatty stools 
 Ankylostoma, Whip worm 
 X RAYS: 
               Barium meal and smell, bowel examination  and  barium enema may show a 
GI disorder. 
 ENDOSCOPY: 
               Proctoscopy for the detection of Piles. 
               Sigmoidoscopy, may reveal the lesions not shown by X rays. 
 JEJUNAL BIOPSY: 
  If no source of  blood  loss is found, the celiac syndrome should be   
excluded by Biopsy. 
 IV UROGRAPHY: 
               If  haematuria 
 Bones - Bone tenderness especially Sterna tenderness may occur. 
 Breast - For evidence of carcinoma. 
 Rectal examination - For Haemorrhoids or Rectal bleeding. Size and   
shape  of Prostate gland. 
 Pelvic examination - In Females with Menorrhagia. 
 Fundus - Retinitis in Anaemia due to Chronic Renal Failure. 
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MANAGEMENT: 
          1.  Correction of dietary deficiency: 
 Intake of iron rich diet. 
 Meats - beef, pork, lamb, liver and other organ meat. 
 Poultry - chicken, duck, turkey, liver. 
 Fish - shell fish, clams, oysters. 
 Leafy greens of the cabbage family, broccoli. 
 Legumes. 
 Yeast leavened whole wheat. 
           2.  Correction of chronic alcoholism. 
         3.  Removal of toxic chemical agent or drug in haemolytic anaemia. 
         4.  Blood transfusion. 
            5. Haematinic should be given in adequate dose for sufficient period of time. 
6. The haematinic should be given in adequate doses for a sufficient period 
        of  time. 
            7. Treatment of underlying cause - Ankylostomiasis, Piles, Menorrhagia, 
                    Leukemia, Liver diseases, Endocrine deficiency, Chronic renal  failure. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
       TRIAL DRUG 
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TRIAL DRUG 
  DRUG NAME: 
   SARAKONDRAI CHOORANAM. 
  INGREDIENTS: 
          Sarakondrai leaves and flowers. 
  SOURCE OF DRUG: 
    The  required  fresh flowers  and  leaves  are  procured  from  Govt  Siddha  
Medical College  Campus . Then  the  plant  was  identified  and  authenticated  by  
the  concerned  Botanist  of  Govt  Siddha  Medical  College, Chennai. 
  STANDARD OPERATIVE PROCEDURE: 
     Fresh samples are collected and they are dried in shade. After that they are 
finely powdered and kept in an air tight container. 
  DOSE:   2 gm  twice  a  day 
  ADJUVANT:   Milk 
  INDICATION: 
            PAANDU 
 REF – Athmaratchamirtham Ennum Vaithya Sara Sangraham.(Page no:598).(57)   
 DRUG STORAGE: 
          The  trial  drug  is  stored  in  clean dry  air  tight container  and  it  is  dispensed     
to  the patients  in  packets.           
ACTIVITY OF TRIAL DRUG 
 SARAKONDRAI: 
 Botanical  Name -  Cassia  fistula 
 Family  - Caesalpinaceae 
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Suvai  -  Thuvarppu, siru kaippu 
Thanmai  - Veppam 
Pirivu  -  Karppu 
Action  -  Laxative,Vermifuge. 
CHEMICAL CONSTITUENTS: 
   Leaves and Flowers of Cassia fistula : 
 Biflavonoids, 
 Triflavonoids, 
 Sennoside A and B, 
 Chrysophanol, 
 Kaempferol, 
 Rhein, 
 Fistulin,  
 Triterpenes, 
 Volatile oil, 
 Procyanidin B2, 
 Chrysophanic acid, 
 β -Sitosterol 
Gunam: 
       The flowers of Sarakondrai plant cures Vellai, Vettai, Paandu, Kamalai, Scabies, 
Eczema, Colic pain, Intestinal disorders  and  strengthening internal organs.
 (58)
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                             MATERIALS AND METHODS 
                                            PROTOCOL 
      The disease Pitha Paandu noi has been described in the text Yugi Vaithiya 
Chinthaamani. 
STUDY DESIGN: 
       A  clinical  study  was  carried  out  in  the  Post  Graduate Department  of  Pothu 
Maruthuvam, Govt  Siddha  Medical  College  attached  to  Arignar Anna Hospital, 
Chennai, during  the  period  of  2015  to  2017. 
     The  study  was  approved  by  Institutional  Ethics  Committee (IEC)  and  the 
approval  number  is  GSMC-CH-ME-4/2015/011. It  was  registered  in  Clinical  
Trials Registry - India (CTRI)  and  the  registration  number  is 
CTRI/2017/06/008735. 
POPULATION AND SAMPLE: 
       The  population  consists  of  all patients  who  were  attending  the  OPD  of 
Arignar  Anna  Hospital, Arumbakkam, Chennai. Sample consists  of  Pitha paandu 
patients who satisfying  the  Inclusion  and  Exclusion criteria mentioned below. 
SAMPLE SIZE: 
      40 patients of  both  the  sexes  of  age  groups  between 18 – 50 yrs  suffering  
from  Pitha paandu  noi  were  treated. 
CRITERIA FOR SELECTION: 
    The  patients  were  subjected  to  pre designed  protocol  comprising  of  following 
clinical manifestations. 
INCLUSION CRITERIA: 
 Pallor of conjunctiva, tongue, nails,  
 Dimness of vision, 
 Faintness, 
 Glossitis, 
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 Angular stomatitis,  
 Dyspnoea, 
 Palpitation, 
 Giddiness, 
 Bitter taste in mouth,  
 Fatigue, 
 Lassitude,  
 Anorexia , 
 Patients having HB below 10 gm 
 Age between 18 – 50 yrs 
 Worm infestations are selected for the study . 
EXCLUSION CRITERIA: 
 Age above 60 yrs 
 HB above 10 gms 
 (Clinical history) 
 History of chronic Renal disorders 
 History of  chronic Liver disorders 
 History of Thalessemia 
 History of Bleeding disorder 
 History of  Myxoedema 
 Vulnerable Populations such as Pregnant women, Lactating mothers, TB 
affected individuals, HIV positive. 
HISTORY TAKING: 
      A detailed history of patients age, occupation, socio economic status, complaints 
and its duration, previous illness, personal habits, menstrual history are recorded in the 
case sheet for each and every patient at the time of admission. Special attention was 
paid to record any past history of blood loss, nutritional deficiency and worm 
infestation. 
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CLINICAL DIAGNOSIS: 
    The following parameters are followed for diagnosing the disease on the basis of 
Siddha system. 
 Poriyaal arithal 
 Pulanaal arithal 
 Vinaathal 
 Envagai thervugal 
 Uyir thadhugal 
 Udal thadhugal 
 These diagnostic tools are very useful in assessing prognosis of the disease during 
treatment. 
LABORATORY INVESTIGATION: 
BLOOD: 
TC, DC, ESR, HB, MCV, PCV, MCH, MCHC, RBC count, Blood Sugar, Urea  and 
Cholesterol. 
URINE: 
Albumin , Sugar, Deposit. 
MOTION: 
Ova, cyst  and  occult  blood. 
TRIAL MEDICINE AND DOSE: 
SARAKONDRAI CHOORANAM – 2gm  bd with milk after food. 
 
 
 
 
 
RESULTS AND 
OBSERVATION 
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                       RESULTS  AND  OBSERVATION 
       
A total number of 40 patients included in the study with signs and symptoms of 
Pitha Paandu were treated in the outpatient Department of Pothu Maruthuvam,  
Government  Siddha Medical College, attached to Arignar Anna Hospital Chennai-
106 during the period of  2015-2017. The  results and observations were tabulated 
regarding the following features. 
 Sex  Distribution 
 Age Distribution 
 Kaalam 
 Paruvakaalam 
 Thinai 
 Occupational status 
 Socio economic status  
 Food habits 
 Aetiological  factors 
 Mukkutram- Vatham, Pitham, Kabam 
 Ezhu Udal Kattugal 
 Ennvagai Thervugal 
 Neikuri 
 Clinical Features and prognosis 
 Assessment  of  results 
 Haemoglobin  level 
 By laboratory investigation 
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1.  SEX DISTRIBUTION 
 
SEX NO. OF CASES PERCENTAGE 
MALE 2 5% 
FEMALE 38 95% 
 
 
 
Inference: 
     Among 40 cases, 38 patients (95%) were females and 2 patients (5%) are 
males 
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2. AGE DISTRIBUTION 
 
AGE IN YEARS NO. OF CASES PERCENTAGE 
15-25 7 17.50% 
26-35 13 32.50% 
36-45 12 30% 
46-60 8 20% 
 
 
 
 
Inference:  
   Out of 40 patients, 13 patients (32.5%) are in the age group of 26-35, 12 
patients (30%) are in the age group of 36-45, 8 patients (20%) are in the age 
of 46-60,7 patients (17.5%) are in the age group of 15-25. 
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3. DISTRIBUTION OF KAALAM 
 
KAALAM NO. OF CASES PERCENTAGE 
    VathaKaalam  
     0-33 years 20 50% 
    PithaKaalam  
    34-66 years 20 50% 
    KabaKaalam  
     67-100 years  0 0% 
 
 
 
 
Inference:  
    Out of 40 patients, 20 patients (50%) comes under Vatha Kaalam and 20 
patients (50%) comes under Pitha Kaalam.  
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4.  PARUVA KAALAM DISTRIBUTION 
PARUVA KAALAM MONTHS NO  OF CASES PERCENTAGE 
Kaarkaalam 
Avani, Puratasi, 
8 20% Mid Aug-Mid Oct 
Koothirkaalam 
Iyppasi, Kaarthigai 
7 17.50% Mid Oct-Mid Dec 
Munpani 
Margazhi, Thai 
9 22.50% Mid Dec-Mid Feb 
Pinpani 
Maasi, Panguni 
10 25% Mid Feb-Mid April 
Elavenil 
Chithirai, vaigasi 
2 5% Mid April- Mid June 
Mudhuvenil 
Aani, Aadi 
5 12.50% Mid June-Mid Aug 
 
 
Inference: 
   Out of 40 patients,10 patients (25%) comes under Pinpani, 9 patients 
(22.5%) comes under Munpani, 8 patients (20%) comes under Kaarkalam, 7 
patients (17.5%) comes under Koothir kaalam,5 patients (12.5%) comes 
under Mudhuvenil Kaalam and 2 patients (5%) comes under Elavenil 
kaalam. 
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5. DISTRIBUTION  OF  THINAI 
 
THINAI NO. OF CASES PERCENTAGE 
Kurinji 5 12.50% 
Mullai 0 0% 
Marutham 15 37.50% 
Neithal 20 50% 
Palai 0 0% 
 
 
 
Inference: 
    Out  of  40  patients  20  patients (50%) comes under Neithal, 15 patients 
(37.5%) comes under Marutham, 5 patients (12.5%) comes under Kurunji. 
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                       6.   OCCUPATIONAL STATUS 
 
 
 
Inference: 
   Out of 40 patients, 8 patients (20%) were students, 5 patients (12.5%) were labours, 
25 patients (62.5%) were house wifes and remaining 2 patients (5%) were office 
going. 
 
 
 
 
 
OCCUPATION NO. OF CASES PERCENTAGE 
Students 8 20% 
Labours 5 12.50% 
House  wife 25 62.50% 
Office   going 2 5% 
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7.  SOCIO-ECONOMIC STATUS 
 
INCOME/ANNUM NO. OF CASES PERCENTAGE 
Low Income group             
(Upto 2 Lakhs) 
35 87.50% 
Middle Income group              
(2- 5 Lakhs) 
5 12.50% 
High Income group          
(Above 5 Lakhs) 
0 0% 
 
 
 
Inference: 
   Out  of  40 patients 5 Patients (12.5%)  belongs  to middle  income group , 35 
Patients (87.5%)  belongs  to  low income  group. 
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                                                 8.  DIETARY HABITS 
 
DIETARY HABITS NO. OF CASES PERCENTAGE  
Vegeterian 8 20% 
Mixed 32 80% 
 
 
 
 
Inference: 
      Out  of  40 Patients, 32 Patients (80%) were mixed diet and 8 Patients 
(20%) were vegetarian.  
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9.  AETIOLOGICAL FACTORS 
 
 
 
 
 
 
Inference:  
   Out  of  40  Patients, 29 Patients (72.5%) were due to nutritional 
deficiency and 11 Patients (27.5%) were due to blood loss. 
 
 
 
 
 
 
 
AETIOLOGY NO. OF CASES PERCENTAGE 
Nutritional deficiency 29 72.5% 
Blood Loss / Menorrhogia 11 27.5% 
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                     10. DISTRIBUTION OF VATHAM 
 
 
 
 
 
 
 
 
 
 
Inference: 
      Pranan  affected  in  all  patients  (100%), Abanan  affected in 20 
patients (50%), Viyanan, Samanan, Kirukaran and Devathatthan affected in 
all patients (100%), Koorman affected in 4 patients (10%).  
 
VATHAM NO OF CASES PERCENTAGE  
Pranan 40 100% 
Abanan 20 50% 
Viyanan 40 100% 
Samanan 40 100% 
Uthanan 0 0 
Nagan 0 0 
Koorman 4 10% 
Kirukaran 40 100% 
Devathatthan 40 100% 
Thananjeyan 0 0 
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11. DISTRIBUTION OF PITHAM 
 
 
 
 
 
 
 
 
 
Inference:  
     Out  of  40 patients, Analagam, Ranjagam and Saathagam affected in all 
patients (100%), Pirasagam affected in 5 patients (12.5%) and Alosagagam 
affected in 4 patients (10%). 
 
 
 
PITHAM NO. OF CASES PERCENTAGE  
Analagam 40 100% 
Ranjagam 40 100% 
Saathagam 40 100% 
Pirasagam 5 12.5% 
Alosagagam 4 10% 
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12. DISTRIBUTION OF KABAM 
 
KABAM NO. OF CASES PERCENTAGE  
Avalambagam 40 100% 
Kilethagam 40 100% 
Pothagam 5 12.5% 
Tharpagam 0 0 
Santhigam 10 25% 
 
 
 
Inference:  
    Out of 40 patients, Avalambagam and Kilethagam affected in all patients 
(100%), Pothagam affected in 5 patients (12.5%) and Santhigam affected in 
10 patients (25%). 
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13.  EZHU UDAL THATHUKKAL 
 
EZHU  UDAL 
THATHUKKAL 
NO. OF CASES PERCENTAGE  
Saram 40 100% 
Seneer 40 100% 
Oon 0 0 
Kozhuppu 0 0 
Enbu 10 25% 
Moolai 0 0 
Suronitham 15 37.5% 
 
 
 
Inference: 
     Out  of  40 patients,  Saaram  and  Senneer  affected  in  all patients  (100%) , 
Suronitham affected  in   15 patients (37.5%)  and  Enbu  affected  in  10  patients 
(25%) 
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14.  ENN VAGAI THERVUGAL 
 
 
 
            
 
 
 
 
 
 
Inference: 
    Naa, Niram, Vizhi and Naadi  were  affected  in  all  patients  (100%),  Malam   
affected  in 20 patients (50% ). 
 
THERVUGAL NO. OF CASES PERCENTAGE 
Naa 40 100% 
Niram 40 100% 
Mozhi 0 0% 
Vizhi 40 100% 
Sparism 0 0 
Malam 20 50% 
Moothiram 0 0 
Naadi 40 100% 
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15.  NAADI 
 
NAADI NO. OF CASES PERCENTAGE 
PithaVatham 20 50% 
Kaba Pitham 10 25% 
Vatha Pitham 10 25% 
 
 
 
Inference: 
    50%  of  cases  had  Pitha Vatha Naadi, 25%  of  cases  had  Kaba  Pitha  Naadi  and  
Vatha Pitham. 
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16. NEIKURI 
NEIKURI NO. OF CASES PERCENTAGE 
Vatham (Snake like) 10 25% 
Pitham (Ring like) 22 55% 
Kabam (Pearl  Like) 8 20% 
 
 
 
INFERENCE: 
      Out of 40 patients, 22 patients (55%) had  Pitha Neer, 10 patients (25%) had Vatha  
Neer  and 8 patients (20%) had  Kaba Neer Neikuri. 
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17. CLINICAL FEATURES 
S. NO SIGNS & SYMPTOMS NO. OF CASES PERCENTAGE 
1 Pallor of  conjunctiva  and nail  bed 40 100 
2 Fatigue 40 100 
3 Loss  of  appetite 40 100 
4 Dyspnea  on exertion 40 100 
5 Headache 18 45 
6 Glossitis 13 32.5 
7 Constipation 20 50 
8 Giddiness 20 50 
9 Tachycardia 18 45 
10 Dimness  of  vision 5 12.5 
 
 
Inference:   
      Out  of  40 patients, 40  patients (100%) had  Pallor  of  conjunctiva  and  nail bed,  
Fatigue, Loss of  appetite, Dyspnea on exertion, 18 Patients (45%) had  Headache, 13 
patients (32.5%) had  Glossitis, 20 patients (50%) had  Constipation, 20 patients (50%) 
had Giddiness, 18 patients (45%)  had Tachycardia  and  5 patients (12.5%) had  
Dimness of  vision. 
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18. CLINICAL PROGNOSIS 
   
S. No 
 
SIGNS&SYMPTOMS 
BEFORE TREATMENT AFTER TREATMENT 
NO. OF 
CASES 
PERCENTAGE 
(%) 
NO. OF 
CASES 
PERCENTAGE 
(%) 
1. Pallor of  conjunctiva  and 
nail  bed 
40 100 8 20 
2. Fatigue 40 100 3 7.5 
3. Loss  of  appetite 40 100 4 10 
4. Dyspnea  on exertion 40 100 6 15 
5. Headache 18 45 5 12.5 
6. Glossitis 13 32.5 6 15 
7. Constipation 20 50 0 0 
8. Giddiness 20 50 0 0 
9. Tachycardia 18 45 4 10 
10. Dimness  of  vision 5 12.5 3 7.5 
 
 
Inference:   
    After  treatment  Pallor of conjunctiva  and  nail bed  present  in  8  patients (20%) ,  
Tachycardia  present  in  4  patients (10%), Loss  of  appetite  present   in  4  patients 
(10%),   Fatigue  present  in  3 patients (7.5%),  Dyspnea on exertion  present  in  6  
patients (15%), Headache  present  in 5 patients (12.5%), Glossitis  present  in  6  
patients (15%)  and  Dimness  of  vision  present  in 3 patients (7.5%) due  to  ageing. 
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                                           HAEMOGLOBIN LEVEL 
 
S.NO 
 
OP.NO 
AGE/ 
SEX 
BEFORE 
TREATMENT 
AFTER 
TREATMENT 
1 3888 40/f 10.0 12.1 
2 9704 35/f 10.0 13.2 
3 4516 41/f 9.8 11.9 
4 5539 30/f 9.0 12.0 
5 6689 34/f 8.3 10.9 
6 6667 23/f 8.8 11.0 
7 9724 32/f 10.0 13.1 
8 1182 32/f 9.1 11.3 
9 138 38/f 9.0 12.3 
10 620 38/f 9.6 12.8 
11 700 44/f 9.2 12.4 
12 1089 19/f 7.5 9.8 
13 1088 20/m 8.6 11.3 
14 1057 28/f 8.7 11.8 
15 5391 22/f 8.6 12.7 
16 2509 27/f 9.9 12.0 
17 2446 26/f 9.5 12.1 
18 2480 30/f 9.8 12.9 
19 6160 38/f 10.0 12.6 
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20 9139 38/f 9.0 12.2 
21 7505 38/f 9.8 12.9 
22 8750 37/f 8.6 11.8 
23 8671 36/f 10.0 13.2 
24 6379 35/f 10.0 12.6 
25 8428 33/f 10.0 12.9 
26 8278 50/f 9.5 12.5 
27 9026 37/f 8.0 11.1 
28 9229 20/f 10.0 13.2 
29 383 24/f 10.0 13.1 
30 1677 42/f 9.9 12.9 
31 2199 42/f 10.0 13.3 
32 2926 35/f 10.0 12.9 
33 2953 47/f 9.8 12.6 
34 3110 30/m 10.0 12.2 
35 4544 42/f 8.0 11.1 
36 5913 41/f 10.0 13.5 
37 2208 48/f 7.6 8.8 
38 6377 40/f 10.0 12.9 
39 756 42/f 10.0 13.0 
40 1197 19/f 8.8 10.4 
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                                              19.  GRADING OF RESULTS 
S. No GRADING OF 
RESULTS 
NO. OF CASES PERCENTAGE% 
1. Good 24 60% 
2. Moderate 10 25% 
3. Mild 6 15% 
 
 
 
 
Good:  Increase  in  Hb level  between  3gms/dl  and  above  after  treatment . 
Moderate: Increase  in  Hb  level  between  2gms/dl to 2.9 gms/dl  after  treatment 
Mild: Increase  in  Hb level  between 0.5gms/dl to 1.5gm/dl  after  treatment . 
 
Inference:       
     Out  of  40  patients, 24 cases (60%) shows  good result, 10 cases (25%) shows  
moderate result, 6 cases (15%)  shows  mild  result. 
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                  LIST OF PATIENTS 
 
S.NO 
 
OP.NO 
AGE/ 
SEX 
DATE OF 
MEDICINE 
STARTED 
TOTAL NO OF 
TREATMENT 
DAYS 
 
RESULT 
1 3888 40/f 19.8.16 48 days Moderate 
2 9704 35/f 7.9.16 48  days Good 
3 4516 41/f 29.9.16 48  days Moderate 
4 5539 30/f 3.10.16 48  days Good 
5 6689 34/f 7.10.16 48  days Mild 
6 6667 23/f 7.10.16 48 days Good 
7 9724 32/f 19.10.16 48 days Good 
8 1182 32/f 15.11.16 48 days Moderate 
9 138 38/f 28.11.16 48 days 
Moderate 
10 620 38/f 30.11.16 48 days 
Good 
11 700 44/f 30.11.16 48 days Good 
 
12 1089 19/f 2.12.16 48 days 
Moderate 
13 1088 20/m 2.12.16 48 days 
Moderate 
14 1057 28/f 2.12.16 48 days Good 
15 5391 22/f 9.12.16 48 days Good 
16 2509 27/f 9.12.16 48 days Good 
17 2446 26/f 9.12.16 48 days Good 
18 2480 30/f 9.12.16 48 days Mild 
19 6160 38/f 26.12.16 48 days Moderate 
20 9139 38/f 29.12.16 48 days Good 
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21 7505 38/f 30.12.16 48 days Good 
22 8750 37/f 4.1.17 48 days Good 
23 8671 36/f 4.1.17 48 days Good 
24 6379 35/f 4.2.17 48 days Moderate 
25 8428 33/f 13.2.17 48 days Mild 
26 8278 50/f 13.2.17 48 days Good 
27 9026 37/f 15.2.17 48 days Good 
28 9229 20/f 13.2.17 48 days Good 
29 383 24/f 20.2.17 48 days Moderate 
30 1677 42/f 24.2.17 48 days Good 
31 2199 42/f 27.2.17 48 days Good 
32 2926 35/f 1.3.17 48 days Good 
33 2953 47/f 1.3.17 48 days Mild 
34 3110 30/m 1.3.17 48 days Good 
35 4544 42/f 6.3.17 48 days Good 
36 5913 41/f 11.3.17 48 days Good 
37 2208 48/f 13.3.17 48 days Mild 
38 6377 40/f 13.3.17 48 days Good 
39 756 42/f 28.3.17 48 days Good 
40 1197 19/f 30.3.17 48 days Moderate 
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LABORATORY INVESTIGATION 
 
S.NO OP.NO 
BEFORE TREATMENT AFTER TREATMENT 
TC 
DC ESR 
TC 
DC ESR 
P L E 1/2 1 P L E 1/2 1 
1 3888 11600 63 31 6 12 25 10900 61 30 7 4 8 
2 9704 9800 62 33 5 18 38 9700 60 29 5 5 9 
3 4516 8300 52 43 5 22 38 8500 58 40 5 6 12 
4 5539 12500 77 16 7 35 75 12000 68 15 6 10 20 
5 6689 6400 50 44 6 23 35 6800 49 46 4 8 16 
6 6667 4900 55 37 8 10 22 4800 54 38 5 12 24 
7 9724 10800 54 39 7 6 15 10700 56 39 8 7 15 
8 1182 6300 48 42 9 6 12 6340 44 44.8 1.3 4 9 
9 138 10700 54 36 6 6 16 10600 52 36 5 6 13 
10 620 6800 64 30 6 16 24 6900 62 32 6 14 28 
11 700 9400 54 40 6 38 62 9500 56 42 7 8 10 
12 1089 7000 59 34 7 8 15 7100 54 36 9 7 10 
13 1088 3500 75 21 4 4 10 3600 76 26 4 7 18 
14 1057 7400 59 35 6 22 35 7600 62 34 6 12 26 
15 5391 7300 60 37 3 6 20 7400 58 32 5 16 34 
16 2509 10100 66 29 5 14 20 10000 70 21 8 10 18 
17 2446 6300 60 33 7 10 21 6500 66 36 6 12 26 
18 2480 9100 73 22 5 14 25 9200 56 42 7 6 13 
19 6160 7700 62 32 6 10 25 7600 66 26 5 8 18 
20 9139 8200 54 39 7 3 7 8300 66 28 7 9 20 
84 
 
21 7505 6900 70 24 6 7 18 7000 72 26 4 6 10 
22 8750 11100 72 25 3 35 60 11200 58 48 6 7 16 
23 8671 3300 78 18 4 14 20 3500 58 46 8 16 36 
24 6379 7200 51 44 5 8 15 7300 52 38 5 8 17 
25 8428 5900 52 40 8 10 18 11100 52 44 3 5 9 
26 8278 8100 57 36 7 25 55 8200 52 38 4 13 26 
27 9026 11000 49 42 9 14 24 11100 65 44 5 8 14 
28 9229 7700 57 35 8 15 28 7800 66 34 6 4 9 
29 383 6200 59 33 8 7 15 6400 66 36 7 12 24 
30 1677 7400 63 31 6 35 80 7300 68 36 3 5 9 
31 2199 10000 74 20 6 20 40 9800 60 30 2 8 10 
32 2926 10100 74 20 6 20 38 10000 58 44 5 7 10 
33 2953 7800 70 22 8 3 7 7900 64 36 1 3 9 
34 3110 10300 58 34 8 12 25 10400 54 32 6 4 12 
35 4544 10000 56 33 4 29 60 9800 58 34 3 20 40 
36 5913 12800 67 28 5 25 40 12700 76 38 7 12 24 
37 2208 9300 62 29 9 22 40 9400 58 46 0 9 18 
38 6377 13900 71 22 7 15 35 14000 60 48 8 8 16 
39 756 8600 53 41 6 5 12 8600 62 38 6 7 16 
40 1197 8100 53 40 7 3 10 8200 56 42 7 8 18 
 
                                      TC-Total count, DC-Differential count, ESR-Erythrocyte Sedimentation Rate, Hb-Haemoglobin. 
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S.NO OP.NO. 
BEFORE TREATMENT AFTER TREATMENT URINE MOTION 
SUGAR UREA CHOL SUGAR UREA CHOL 
A S P 
O C OB 
(mg/dl) (mg/dl) (mg/dl) (mg/dl) (mg/dl) (mg/dl) BT AT BT AT BT AT 
1 3888 133 26 170 100 24 168 N N N N N N N N N 
2 9704 98 28 178 104 22 170 N N N N N N N N N 
3 4516 86 20 206 90 20 182 N N N N N N N N N 
4 5539 103 24 162 110 26 204 N N N N N N N N N 
5 6689 85 24 170 106 24 166 N N N N N N N N N 
6 6667 98 22 179 102 22 176 N N N N N N N N N 
7 9724 72 21 160 107 20 172 N N N N N N N N N 
8 1182 98 26 178 97 30 176 N N N N N N N N N 
9 138 75 19 170 88 21 169 N N N N N N N N N 
10 620 110 22 190 98 19 180 N N N N N N N N N 
11 700 97 23 184 89 21 182 N N N N N N N N N 
12 1089 95 25 165 94 24 168 N N N N N N N N N 
13 1088 92 26 164 108 20 160 N N N N N N N N N 
14 1057 78 32 170 98 33 168 N N N N N N N N N 
15 5391 71 36 162 89 31 170 N N N N N N N N N 
16 2509 100 29 186 120 27 182 N N N N N N N N N 
17 2446 73 38 170 109 34 178 N N N N N N N N N 
18 2480 103 30 155 100 30 152 N N N N N N N N N 
19 6160 73 27 187 98 35 180 N N N N N N N N N 
20 9139 107 18 179 92 27 175 N N N N N N N N N 
21 7505 90 22 176 104 25 156 N N N N N N N N N 
22 8750 86 29 179 105 22 170 N N N N N N N N N 
23 8671 109 23 160 110 30 164 N N N N N N N N N 
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24 6379 95 21 174 103 27 168 N N N N N N N N N 
25 8428 76 22 162 109 29 158 N N N N N N N N N 
26 8278 70 18 160 98 20 170 N N N N N N N N N 
27 9026 85 22 175 121 35 174 N N N N N N N N N 
28 9229 86 26 158 98 33 160 N N N N N N N N N 
29 383 75 20 184 106 28 188 N N N N N N N N N 
30 1677 80 29 190 121 24 174 N N N N N N N N N 
31 2199 84 23 164 95 31 160 N N N N N N N N N 
32 2926 84 19 164 108 35 160 N N N N N N N N N 
33 2953 90 27 160 96 22 167 N N N N N N N N N 
34 3110 98 30 180 109 30 170 N N N N N N N N N 
35 4544 180 19.9 130 100 20 140 N N N N N N N N N 
36 5913 80 24 165 110 29 161 N N N N N N N N N 
37 2208 98 29 160 105 19 166 N N N N N N N N N 
38 6377 71 22 175 104 24 164 N N N N N N N N N 
39 756 95 24 171 109 19 176 N N N N N N N N N 
40 1197 96 27 174 107 28 178 N N N N N N N N N 
 
                   Hb- Haemoglobin,  Blood sugar (R), Urea, CHO-Cholesterol, O-Ova, OB-Occult blood, C-Cyst, D-Deposits. 
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BLOOD INVESTIGATION 
BEFORE TREATMENT 
 
S. 
N
O 
 
OP. 
NO 
AGE/ 
SEX 
Hb/ 
Gms 
RBC 
cells/ 
cumm 
PCV 
% 
MCV 
FI 
MCH 
Pg 
MCHC 
% 
1 3888 40/f 10.0 4.3 26 70 20 29 
2 9704 35/f 10.0 3.3 30 63 21.1 31 
3 4516 41/f 9.8 3.2 29 60 29 33 
4 5539 30/f 9.0 3.8 28 71 28 30 
5 6689 34/f 8.3 3.7 27 73 17 30 
6 6667 23/f 8.8 3.5 24 67 20 32 
7 9724 32/f 10.0 4.1 26 68 24 28 
8 1182 32/f 9.1 3.7 22 65 22.2 33.8 
9 138 38/f 9.0 4.4 21 62 26 29 
10 620 38/f 9.6 3.8 24 70 21 30 
11 700 44/f 9.2 3.1 22 66 18 31 
12 1089 19/f 7.5 4.0 26 64 27 33 
13 1088 20/m 8.6 4.2 25 73 25 32 
14 1057 28/f 8.7 3.6 27 69 21.3 34 
15 5391 22/f 8.6 3.8 24 65 19 36 
16 2509 27/f 9.9 3.2 28 64 23 29.1 
17 2446 26/f 9.5 3.3 29 74 22 32 
18 2480 30/f 9.8 3.5 26 72 27 35 
19 6160 38/f 10.0 4.1 24 68 26.2 36 
20 9139 38/f 9.0 3.3 25 58 19.4 28 
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21 7505 38/f 9.8 3.6 22 65 21.2 27 
22 8750 37/f 8.6 3.8 29 72 20.3 34 
23 8671 36/f 10.0 4.2 25 69 31 32 
24 6379 35/f 10.0 4.4 27 67 21 40 
25 8428 33/f 10.0 3.5 28 63 28 38 
26 8278 50/f 9.5 3.7 26 76 19.5 25 
27 9026 37/f 8.0 3.2 30 70 25.2 28 
28 9229 20/f 10.0 4.1 26 77 22 26 
29 383 24/f 10.0 4.2 28 68 18 29 
30 1677 42/f 9.9 3.4 22 70 23 33 
31 2199 42/f 10.0 3.8 26 65 28 37 
32 2926 35/f 10.0 3.9 26 69 24.2 36 
33 2953 47/f 9.8 4.1 30 74 26 34 
34 3110 30/m 10.0 3.6 27 62 29 26 
35 4544 42/f 8.0 3.9 25 66 21.3 30 
36 5913 41/f 10.0 4.1 22 68 21 25 
37 2208 48/f 7.6 3.3 28 76 25 23 
38 6377 40/f 10.0 3.7 24 74 20 21 
39 756 42/f 10.0 4.4 26 66 17 38 
40 1197 19/f 8.8 3.9 29 68 23 28 
 
Hb - Haemoglobin, PCV - Packed cell volume, MCV -  Mean corpuscular 
volume, MCH - Mean corpuscular haemoglobin,  MCHC - Mean corpuscular 
haemoglobin concentration. 
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AFTER TREATMENT 
 
S. 
N
O 
 
OP.
NO 
AGE/ 
SEX 
Hb/ 
Gms 
RBC 
cells/ 
cumm 
PCV 
% 
MCV 
FI 
MCH 
Pg 
MCH
C 
% 
1 3888 40/f 12.1 4.4 28 74 26 31 
2 9704 35/f 13.2 3.5 32 78 27.2 34 
3 4516 41/f 11.9 3.6 33 68 33 36 
4 5539 30/f 12.0 3.9 30 88 36 32 
5 6689 34/f 10.9 3.8 29 93 21 31 
6 6667 23/f 11.0 3.6 26 80 29 33 
7 9724 32/f 13.1 4.0 28 79 34 30 
8 1182 32/F 11.3 5.9 22 85 22 33 
9 138 38/f 12.3 4.2 24 78 36 30 
10 620 38/f 12.8 3.9 26 82 30 32 
11 700 44/f 12.4 3.3 24 78 26 33 
12 1089 19/f 9.8 4.1 28 74 36 35 
13 1088 20/m 11.3 4.3 29 90 30 36 
14 1057 28/f 11.8 3.8 26 82 26 38 
15 5391 22/f 12.7 3.9 30 80 28 37 
16 2509 27/f 12.0 3.4 32 76 30 31 
17 2446 26/f 12.1 3.5 28 88 32 34 
18 2480 30/f 12.9 3.7 26 90 29 37 
19 6160 38/f 12.6 4.2 28 80 31.2 39 
20 9139 38/f 12.2 3.5 26 70 22.2 30 
21 7505 38/f 12.9 3.7 24 78 27 29 
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22 8750 37/f 11.8 3.9 30 86 26 35 
23 8671 36/f 13.2 4.3 27 80 34 34 
24 6379 35/f 12.6 4.5 29 74 28 41 
25 8428 33/f 12.9 3.7 31 76 32 40 
26 8278 50/f 12.5 3.9 28 88 24 27 
27 9026 37/f 11.1 3.5 32 86 28 30 
28 9229 20/f 13.2 4.3 28 87 26 28 
29 383 24/f 13.1 4.4 30 80 22 31 
30 1677 42/f 12.9 3.6 24 86 26 35 
31 2199 42/f 13.3 3.9 28 78 32 39 
32 2926 35/f 12.9 4.2 30 82 28.6 38 
33 2953 47/f 12.6 4.3 24 86 31 36 
34 3110 30/m 12.2 3.8 28 74 34 28 
35 4544 42/f 11.1 4.1 32 78 26.2 32 
36 5913 41/f 13.5 4.2 29 78 27 27 
37 2208 48/f 8.8 3.5 30 86 28 25 
38 6377 40/f 12.9 3.8 26 86 26 24 
39 756 42/f 13 4.5 28 76 22 38 
40 1197 19/f 10.4 4.1 31 80 29 30 
 
 
 
 
 
 
DISCUSSION 
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DISCUSSION 
            “Pitha Paandu,”  a  nutritional deficiency disease described  by Yugi Munivar  
in  his Yugi  Vaidhya  Chinthamani  800. The  clinical  features  are  pallor  of  
conjunctiva  and  nail bed, fatigue, loss of appetite, dyspnoea on exertion, headache, 
giddiness, glossitis, constipation, parasthesia  in  fingers  and  toes. The symptoms  of  
Pitha Paandu  are  mostly similar  to  that  of  symptoms  of   Iron deficiency  anaemia. 
It is one of the micro nutrient disorder and its prevalence rate is higher among Indians 
due to lack of nutrition and education. It is estimated that globally, nearly two billion 
people are affected by Iron deficiency anaemia.     
         The patients  were  examined based on Siddha  and  as well as Modern aspects. 
The results obtained from their studies were discussed below for better conclusion.    
          40 patients were treated in the outpatient  Department of Pothu Maruthuvam, 
Government Siddha Medical College, attached to Arignar Anna Hospital, 
Arumbakkam, Chennai -106. The time duration  for  treatment  was 48  days  and  all 
necessary  investigations were carried  out  to  all  patients  and  trial  medicine  was  
given  and  followed  up regularly  in the OP department once in 7 days. 
1. Drug authentication 
          The  fresh  samples  of  Sarakondrai  leaves  and  flowers  are  authenticated   
based upon the organoleptic/macroscopic/microscopic examination by the  concerned  
Botanist  from  Govt  Siddha  Medical  College, Arumbakkam, Chennai. 
2. Physicochemical  analysis 
 The  total  ash  value  of  Sarakondrai chooranam was 9.34% 
 The  acid  insoluble ash  value was  1.92% 
 The  water  soluble ash value was  4.63% 
 Alcohol  soluble  extractive  value was 24.75% 
 Water  soluble  extractive  value was  31.47% 
3. IAEC (Institutional Animal Ethics Committee) 
           All the protocols and the experiments conducted  in strict  compliance 
according to ethical principles and guidelines provided by committee for the purpose 
of control and supervision  of  experiments  on Animals (CPCSEA). The animal 
experimental protocol was approved by the IAEC of Sathyabama University, Chennai. 
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4. Toxicity study 
 
  Acute Toxicity Study 
    Acute toxicity study of the study drug Sarakondrai  Chooranam was carried out as 
per  OECD guideline (Organization for Economic Co-operation and Development) 
Guideline-423.  
 
 Sub-acute toxicity 
    Sub-acute toxicity study of the study drug Sarakondrai  Chooranam was carried out 
as per OECD guideline (Organization for Economic Co-operation and Development) 
Guideline-407. The experimental protocol  was  approved by the IAEC of Sathyabama 
University, Chennai. IAEC Approval No: SU/CLATR/IAEC/IV/018/2016. 
. 
Hematological analysis 
   When compared to the control group, treatment groups has no significant  
difference and hence treatment groups has no toxicity and haematological differences. 
 
Biochemical analysis 
    No significant difference between control and treatment groups and found no 
impacts in serological functions in treatment groups. 
 
Histopathological evaluation 
     Histopathological evaluation shows no hepatotoxic, nephrotoxic, neurotoxic 
contents in the trial drug. 
Statistical analysis 
    The statistical analysis was carried by one way ANOVA (GRAPH PAD PRISM 5 
computer program). Results were expressed as mean ± standard error. A statistical 
comparison was carried out using the Dunnet’s test for the control and treatment 
group. 
5.Pharmacological study 
    Pharmacological  Evaluation  of  Sarakondrai Chooranam on Phenyl hydrazine 
induced Anaemia in wistar rats  has been approved by the IAEC  of  Sathyabama 
University, Chennai. IAEC Approval No: SU/CLATR/IAEC/IV/018/2016. 
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6. Bio-Chemical Analysis 
       The  Bio-chemical  analysis  of  Sarakondrai chooranam  contains  Iron, Copper, 
Reducing sugar  and  Alkaloids. 
 
7. Institutional Ethics Committee (IEC) 
        The  study  was  approved  by  Institutional  Ethics  Committee (IEC)  and the 
approval number  is  GSMC-CH-ME-4/2015/011. It  was  registered  in  Clinical  
Trials  Registry – India (CTRI) and  the  registration  number  is  
CTRI/2017/06/008735. 
8. Clinical study 
       Blood and Urine Investigations were  taken  before and  after treatment. 
       All  the  patients  were  treated  with the trial drug Sarakondrai chooranam  for  
an  average of 48 days. Blood  and  urine were once again  tested  after  the completion 
of  treatment. 
Sex: 
      Among  40 cases, 38 Patients (95%) were Females  and  2  Patients (5%)  were  
Males.  Females  are mostly affected  than  Males   due  to  menstrual  blood  loss  and 
malnourished  diet. 
Age: 
       Out  of  40 patients, 7 Patients (17.5%) were in the age group of 15-25,  13 
Patients (32.5%) were in the age group of  26-35,  12 Patients (30%) were in the age 
group of 36- 45, 8 Patients (20%) were  in  the  age  group of  46-60. The incidence 
was  increased  in the age  group  of  15-45  due  to  menstrual  blood  loss. 
Kaalam: 
      Out  of  40  patients, 20 Patients (50%) comes under Vatha Kaalam and 20 Patients 
(50%) comes under  Pitha Kaalam. 
Paruvakaalam: 
      Out of 40 patients, 10 patients (25%) comes under Pinpani, 9 patients (22.5%) 
comes under Munpani, 8 patients (20%) comes under Kaarkalam, 7 patients (17.5%) 
comes under Koothir kaalam, 5 patients (12.5%) comes under Mudhuvenil Kaalam 
and 2 patients (5%) comes under Elavenil kaalam. 
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Thinai: 
       Out of 40 patients, 20 Patients (50%) comes under Neithal , 15 patients (37.5%) 
comes under Marutham and  5  patients (12.5%)  comes under Kurinji. 
Occupation: 
        Out  of  40 patients, 8 Patients (20%)  were students,  5 patients (12.5%) were 
Labourers , 25  Patients (62.5%) were house  wives  and remaining  2 patients (5%) 
were  office  going. 
Socio-economic status: 
 Out  of  40 patients, 5 Patients (12.5%)  belongs  to  middle  income group , 35      
patients (87.5%)  belongs  to  low  income  group.  Economically  low  income 
group were more affected than middle or high  income group due to their  
malnourished diet. 
Diet: 
        Out  of  40 patients, 32 Patients (80%) were  mixed  diet  and  8 Patients (20%) 
were vegetarian. 
Aetiological  factors: 
        Out  of  40  patients, 29  patients (72.5%)  were  due to  nutritional  deficiency 
and 11 patients (27.5%)  due  to  blood  loss.  So, the  nutritional  deficiency  plays  a  
major  role  in  causing  Iron  deficiency Anaemia. 
Mukkutram: 
Vatham: 
 Praanan  was  affected  in  all  the  patients (100%)  reflected  as  dyspnoea  on 
exertion. 
 Abanan was affected in 20 patients (50%) reflected as constipation and  
menorrhagia. 
 Viyanan  was  affected  in  all patients (100%)  reflected  as  joint pain. 
 Samanan  was  affected  in  all  patients  (100%)  reflected as  loss of appetite. 
 Koorman was affected in 4 patients (10%) reflected as dimness of vision. 
 Kirugaran  was  affected  in  all patients  (100%)  reflected  as  loss of  appetite  
and   Devathathan   was  affected  in  all  patients (100%)  resulting  in  fatigue. 
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Pitham: 
 Analagam  was  affected  in all  patients  (100%) producing  loss  of  appetite. 
 Ranjagam  was  affected  in  all  patients (100%) resulting  in pallor  of  
conjunctiva  and  nail bed. 
 Saathagam was  affected  in  all  patients (100%).  
 Pirasagam  was  affected  in  5 patients (12.5%)  resulting  in   pallor of  skin. 
 Alosagam was affected  in 4 patients (10%) reflected as dimness of vision. 
Kabam: 
 Avalambagam was  affected  in  all  patients (100%)  resulting  in  dyspnoea  
on exertion. 
 Kilethagam was affected in  all  patients (100%) resulting  in  loss  of  appetite. 
 Pothagam was affected  in  5 patients (12.5%) resulting  in loss of  taste or 
bitter taste. 
 Santhigam was  affected  in  10 patients (25%) resulting  pain in knee joints. 
Ezhu udal thathukkal: 
 Saaram  was  affected  in  all patients (100%)  causing  tiredness.  
 Senneer  was affected  in all patients (100%)  producing  pallor  of conjunctiva  
and  nail bed. 
 Suronitham  was  affected  in  15 patients (37.5%) reflected  as  menorrhagia. 
Ennvagai  thervugal: 
 All  patients  Naa, Niram , Vizhi  and Naadi were affected  reflected  as  pallor  
of conjunctiva and nail bed. 
 Malam  was  affected  in  20  patients (50%)  due to constipation. 
Naadi: 
 50%  of  cases  had  Pitha Vatha Naadi,  
“இட஫ான சேத்து஫த்தில் பித்த நாடி 
    எழுந்தனுகில் விடமுடசன வகீ்கமுண்டாம் 
................................................................................ 
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விட஫ான நநஞ்ேடடப்பு சுவாேம் விக்கல் 
     நவகுசுரமும் நாவறட்ேி பாண்டுசராகம்” 
 
 25%  of  cases  had  Kaba Pitha Naadi and Vatha Pitha Naadi. 
Neikuri:  
 Out  of  40  patients, 22  patients (55%)  had  Pitha Neer, 10 patients (25%) had 
Vatha  Neer  and 8 patients ( 20%) had  Kaba Neer Neikuri. 
Investigations: 
       Investigations like TC, DC, ESR, Hb, PCV, MCV, MCH, MCHC, Blood Sugar, 
Blood Urea, Serum Creatinine  and  Routine  Urine and Motion Test  were  taken  
before and  after treatment. 
 
Clinical  symptoms: 
       Out  of  40  patients, 40  patients (100%) had  Pallor  of  conjunctiva  and  nail 
bed, Fatigue, Loss of appetite, Dyspnea on exertion, 18 Patients (45%) had  Headache, 
13 patients (32.5%) had  Glossitis, 20 patients (50%) had Constipation  and  
Giddiness,  18 patients (45%)  had  Tachycardia  and  7 patients (17.5%) had  Dimness  
of  vision. 
Clinical  Prognosis: 
       After  treatment  Pallor of conjunctiva  and  nail bed present  in 8 patients (20%),  
Loss of appetite and Tachycardia present  in 4 patients (10%), Fatigue  present  in 3 
patients (7.5%),  Dyspnea  on  exertion  present  in  6  patients (15%), Headache  
present  in 5 patients (12.5%) and  Dimness  of  vision  present  in  3  patients (7.5%). 
 
Haemoglobin  level: 
      Out of 40 patients,  
 22 cases shows increase in Hb level between 3gms/dl and above after  
treatment (55%). 
 11 cases shows increase in Hb level between 2gms/dl to 2.9 gms/dl after  
treatment (27.50%). 
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 7 cases shows  increase  in Hb level between 0.5gms/dl to 1.5gm/dl  after  
treatment (17.5%). 
Trial medicine: 
 Sarakondrai chooranam  was  administered  2 gm BD  with milk  after food 
for 48 days. 
 The taste of Sarakondrai chooranam is principally thuvarppu. In Pitha 
Paandu, pitham  is deranged  and  the deranged  pitha kuttram  was  neutralized  
by  thuvarppu  suvai  there by it act on Ethirurai  maruthuvam. 
Qualitative analysis: 
 In  Sarakondrai chooranam, basic radicals like Iron, Copper, Alkaloids were 
present. 
Toxicological studies: 
            The results of acute toxicity study of Sarakondrai chooranam revealed no                      
            mortality, no abnormal  signs  and  behavioral changes  in  rats  at  the dose of       
            2000 mg/ kg   body weight  administered orally. 
Acute and Sub-Acute oral toxicity: 
 At the end of the studies the animals were sacrificed and the haematological 
parameters,  biochemical  parameters, urine parameters  and  histopathology  of  
vital organs like liver, heart, spleen and  kidney  were  carried out. 
 The  study  results  show  that  the  trial drug was safe  and  did not produced 
any toxic effects. 
Pharmacological study: 
 The induction of Anaemia in rats was  performed by the intraperitoneal 
administration of  40 mg/kg  of  Phenyl hydrazine (PHZ)  for  two  days. The 
trial drug were given single oral dose daily for 3 weeks and the results were 
observed . 
 After the administration of test drug Sarakondrai chooranam, the 
hematological parameters are significantly increased (P ≤ 0.001). 
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Bio statistical report: 
 
 The bio statistical report reveals that, the trial medicine shows a significant 
improvement  with P value ˂ 0.001 and  the mean difference of  Hb level  
before and after treatment  is  2.92±0.07 (gm/dl), also there is a significant 
reduction in signs and symptoms among  the  patients. Hence  it  is concluded 
that the treatment was effective and significant.  
 It results as the treatment was significantly improving the HB level (gms/dl).  
 Since, the  p  value  is  highly significant ( p<0.001) in  all  signs  and  
symptoms  there  is  significant  reducing  of  signs  and  symptoms  among  
the  patients  for  the treatment  of  Pitha paandu (Iron deficiency anaemia). 
Hence, it  is  concluded  that  the  treatment  was effective and significant. 
 
Grading  of  results: 
          Out of 40 patients, 24 cases (60%) shows  good result, 10 cases (25%) shows     
           moderate result, 6 cases (15%)  shows  mild  result after treatment. 
 
 
 
 
 
SUMMARY 
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                                              SUMMARY 
 The clinical study on  PITHA PAANDU was carried out in Post graduate 
department of  Maruthuvam, Government Siddha Medical College, attached to 
Arignar Anna Hospital, Chennai –106  during the period  of  2015 - 2017. 
             40 patients were treated in the outpatient department. The clinical and 
pathological  assessment  was  carried  out  on  the  basis of  both  Siddha  and  
Modern aspects. 
            All  the  40 patients were treated with  Sarakondrai chooranam (2 gm/bd daily 
with milk). The duration of the treatment was fixed as 48 days. The patients are 
monitored once in 7 days.  
The results obtained from the studies are summarized below: 
 The prevalence was  found to be higher  in females  (95%). 
 High incidence of patients were noted  in the age group of  26 -35 years 
(37.5%).  
 Out of 40 patients, 50% of cases comes under Vatha Kaalam and 50% of cases 
comes under   Pitha  Kaalam. 
 Majority of  patients  comes under  Pinpani  kaalam (25%).  
 In Thinai, Neithal thinai (50%) and Marutham thinai (37.5%) people are 
mostly affected. 
 In Occupational  status,  housewife (62.5%)  was  mostly affected. 
 Economically  low  income group (87.5%) were  more  affected. 
 Among dietary patterns, (80%) of patients were mixed diet. 
 Aetiological factors, Nutritional deficiency (72.5%) plays a  major role in 
Pitha Paandu. 
 In Vatham, Piranan, Viyaanan, Samanan, Kirugaran, Devathathan  were 
affected in all patients. 
 In  Pitham,  Analagam, Ranjagam, Sathagam were affected  in all patients.  
 In  Kabam,  Avalambagam, Kilethagam were affected in all patients. 
 In  Ezhu udal thathukal,  Saaram and Senneer were affected in all patients. 
 In  Envagai  thervugal, Naa, Niram and Vizhi were affected in all patients. 
 Most of  the  patients  had  Pitha Vatha  naadi (50%). 
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 The clinical trial shows that there is significant improvement in the clinical 
manifestations of  Pitha Paandu. 
 Regarding Haemoglobin level, 22 cases shows increase  in  Hb level  between 
3gms/dl and above after  treatment (55%), 11 cases shows increase  in  Hb 
level between 2gms/dl to 2.9 gms/dl after  treatment (27.50%) and 7 cases 
shows  increase  in Hb level between 0.5gms/dl to 1.5gm/dl  after  treatment 
(17.5%) 
 The trial medicine having  thuvarppu  suvai  which  neutralizes the deranged 
Pitham by Ethirurai maruthuvam.  
 Also the trial drug have Vermifuge and Laxative activity. 
 In Qualitative analysis, basic radicals like Iron, Copper, Alkaloids and 
Reducing sugar were present. 
 The pre-clinical studies shows that the trial medicine was safe with significant  
Haematinic activity. 
 The Bio statistical  report of the clinical trial shows significant P value ˂0.001 
and concluded that, the treatment is effective and significant. 
 Among 40 patients, 24 cases (60%) shows  Good result, 10 cases (25%) shows 
Moderate result, 6 cases (15%)  shows  Mild  result after treatment.                                    
 
 
 
 
 
 
 
CONCLUSION 
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CONCLUSION   
 Pitha Paandu  is  primarily  due  to the derangement of  pitham . 
 The trial medicine Sarakondrai Chooranam predominating  with Thuvarppu  
taste it  neutralizes the deranged pitham by Ethirurai Maruthuvam.  
 The trial medicine Sarakondrai Chooranam  is economical. 
 From the Pre Clinical Toxicological studies, Sarakondrai Chooranam reveals 
no toxicity  and  hence proved to be  safe. 
 From the Pre Clinical Pharmacological studies, it reveals that the Sarakondrai 
Chooranam  possess  significant  Haematinic activity. 
 No adverse effects was  reported during the course of the treatment. 
 In Clinical study, Sarakondrai Chooranam  gave maximum relief from the 
symptoms of  Pitha Paandu  and  increases  the  Haemoglobin level. 
 Therefore I conclude that Sarakondrai Chooranam is an effective  Haematinic 
drug for the remedy of  Pitha Paandu . 
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Project Report on Toxicity Profiling of Sarakondrai Chooranam 
 
Name   Dr. M. Shanmuga Priya 
 
IAEC   SU/CLATR/IAEC/IV/018/2016 
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ACUTE TOXICITY 
Sarakondrai Chooranam was carried out as per OECD guideline (Organization for 
Economic Co-operation and Development) Guideline-423. 
Animal 
Healthy adult Wistar albino rat weighing between 170-200 g were used for the 
study.  The animals were housed in poly propylene cages and were kept in well 
ventilated with 100% fresh air by air handling unit (AHU). A 12 light / dark cycle 
were maintained .Room temperature was maintained between 22 + 2
0 
Cand relative 
humidity 50–65%. They were provided with food (Sai feeds, Bangalore, India) and 
water ad libitum. All the animals were acclimatized to the laboratory for 7 days prior 
to the start of the study. 
The experimental protocol was approved by The Institutional Animal Ethics 
Committee of Sathyabama University, Chennai, Tamil Nadu, India. 
Acute toxicity Study 
Acute toxicity study will be carried out in accordance with OECD guideline 
423
(59)
 . The animals were fasted overnight with free access to water. The study was 
conducted with single oral dose administration of Sarakondrai Chooranam.  
IAEC SU/CLATR/IAEC/IV/018/2016 
Animal Grouping 
One group consist of 6 female rats were used for this study . The dose utilized 
for evaluation of acute toxicity study is about 2000 mg/kg higher than that of the 
therapeutic dose.  
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Animal Grouping 
GROUP I : Animals received Test drug 2000 mg/kg (p.o)  
The animals were fasted overnight (12- 16 hrs) with free access to water. The 
study was conducted with single oral administration of study drug  Sarakondrai 
Chooranam 2000mg/kg (p.o). The animals were observed continuously for first 72 h 
and then 14 days for emerging signs of behavioral changes, body weight changes and 
for mortality. 
Occurrence of toxicity in animals were observed continuously for the first 4 to 
24 h and observed periodically for the next 14 days.  Observation includes the change 
in skin, fur, eyes and mucus membrane. Appearance of C.N.S,C.V.S and A.N.S related 
toxicity such as tremors, convulsions, sedation, steric behavior, respiratory distress, 
cardiovascular collapse, response to sensory stimuli, salivation, diarrhea, lethargy, 
sleep, coma and mortality were observed with special attention. 
Body weight was recorded periodically. At the end of the experiment all 
animals were subjected for gross necropsy and observed for pathological changes. 
 
SUB-ACUTE TOXICITY STUDY 
Sub-acute toxicity study was carried out as per OECD guidelines Guideline-
407. 
(60)
 
Animals 
Healthy adult Wistar albino rat weighing between 170-200 g were used for the 
study.  The animals were housed in poly propylene cages and were kept in well 
ventilated with 100% fresh air by air handling unit (AHU). A 12 light / dark cycle 
were maintained. Room temperature was maintained between 22 + 2
o 
Cand relative 
humidity 50–65%. They were provided with food (Sai feeds, Bangalore, India) and 
water ad libitum. All the animals were acclimatized to the laboratory for 7 days prior 
to the start of the study. 
The experimental protocol was approved by The Institutional Animal Ethics 
Committee of Sathyabama University, Chennai, Tamil Nadu, India. 
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IAEC SU/CLATR/IAEC/IV/018/2016 
  Animal Grouping 
Animals were divided into three groups of 06 animals each consist of 3 male 
and 3 female rats. 
GROUP I : Animals received saline 5 ml/kg b.w (p.o)             
GROUP II : Animals received low dose of test drug 200 mg/kg (p.o) 
GROUP III : Animals received high dose of test drug 400 mg/kg (p.o) 
The animals were randomly divided into control group and drug treated groups 
for two different doses viz. low dose (200 mg/kg b.w) and high dose (400 mg/kg b.w). 
The animals were administrated with the study drug once daily for 28 days. 
The animals in group I (control group) received normal saline 5 ml/kg b.w. The 
animals in group II received low dose of Sarakondrai Chooranam 200 mg/kg b.w(p.o) 
and group III received high dose of Sarakondrai Chooranam 400 mg/kg b.w(p.o). 
The rats were weighed periodically and observed for signs of toxicity pertains 
to C.N.S, C.V.S, A.N.S including behavioral changes, food - water intake and 
morphological changes. At the end of 28
th
 day, the animals were fasted for overnight 
with free access to water. On 29
th
 day the animals were sacrificed with excess 
anesthesia. Blood samples were collected from aorta and stored in EDTA 
(ethylenediamine –tetra actate) for Hematological analysis and for serum generation 
for biochemical analysis. 
The vital organs including heart, brain, lungs, spleen, kidneys, liver, stomach, 
testes, and ovary were harvested and carefully examined for gross lesions. The organs 
were preserved in 10% formalin for histopathological assessment and interpretation. 
Hematological analysis 
Blood samples were analyzed using established procedures and automated 
Bayer Hematology analyzer. Parameters evaluated include Packed Cell Volume 
(PCV), Red Blood Cells (RBC) count, White blood cell count (WBC), Platelet Count, 
Hemoglobin (Hb), Mean cell Haemoglobin Concentration (MCHC), Mean Red Cell 
Volume (MCV), Mean Cell Hemoglobin (MCH), Mean platelet volume (MPV), 
Neutrophils, Eosinophil’s, Basophils, Lymphocytes and Monocytes.  
Biochemical analysis
(61)
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Serum samples were analyzed for High Density Lipoprotein (HDL), Low 
density Lipoprotein (LDL) , Very low density Lipoprotein (VLDL) , Triglycerides 
(TGL), Total Cholesterol , Blood urea nitrogen (BUN), Creatinine, Albumin, Total 
Protein, Glucose, Uric acid, Aspartate Transaminase (AST), Alanine amino 
Transaminase (ALT) and Alkaline  Phosphatase (ALP) using Mind ray auto analyzer 
model BS 120. 
Histopathological evaluation
(62)
 
 Organs included of heart, brain, lungs, spleen, kidneys, liver, stomach, testes 
and ovary. Histological slides of organs were made and observed under the 
microscope.  The pathological observations of cross section of these organs were 
performed on gross and microscopic bases. Histological examinations were performed 
on the preserved tissues with particular emphasis on those which showed gross 
pathological changes. 
Statistical analysis 
The statistical analysis was carried by one way ANOVA (GRAPH PAD 
PRISM 5 computer program). Results were expressed as mean ± standard error .A 
statistical comparison was carried out using the Dunnet’s test for the control and 
treatment group.  
. 
RESULTS 
Assessment of clinical signs in rats treated with Sarakondrai Chooranam  in Acute 
toxicity study 
Parameter Group I 
Clinical Signs Parameters for the duration of 14 days Test Drug 2000mg/ Kg    
Number of animals observed 6 Female  
Lacrimation Absence 
Salivation Absence 
Animal appearance Normal 
Tonic Movement Absence 
Clonic Movement Absence 
Laxative action Absence 
Touch Response Normal 
Response to Sound Normal Response 
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Response to Light Normal Response 
Mobility Normal Response 
Respiratory Distress Nil 
Skin Color Normal 
Stereotype behaviour Absence 
Piloerection Absence 
Limb Paralysis Absence 
Posture Normal 
Open field behaviour Normal 
Gait Balancing Normal 
Freezing Behaviour Absent 
Sings of Stress and Anxiety None Observed 
Muscular coordination Normal 
Muscle grip Normal 
Sedation Absence 
Social Behavior Normal 
Urine Analysis No Abnormality 
Urine Colour Yellowish 
Urine Ph 7 
Urine -Glucose                         Absence 
Urine -Ketones                        Absence 
Urine- Bilirubin                         Absence 
Urine-Blood  Cells       Negative 
Urine - Pus cells Negative 
Mortality Nil 
 
 
Quantitative data on the body weight of rats treated with Sarakondrai 
Chooranam in Acute toxicity study 
Group I Before Treatment Weight in Gms After Treatment Weight in Gms 
Mean 182.5 185.8 
Std. Deviation 6.565 6.432 
Std. Error 2.68 2.626 
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Values are mean ± S.D (n = 6 per group). Control and treatment group were compared 
statistically using one way ANOVA followed by Dunnett’s test. 
Assessment of clinical signs in rats treated with Sarakondrai Chooranam on Sub-
Acute toxicity study 
Parameter Group I Group II Group III 
Clinical Signs 
Parameters for the 
duration of  28 days Control 
Test Drug 
200mg/ Kg    Test Drug 400mg/ Kg    
Number of animals 
observed 
3 Male and 3 
Female 
3 Male and 3 
Female 3 Male and 3 Female 
Lacrimation Absence Absence Absence 
Salivation Absence Absence Absence 
Animal appearance Normal Normal Normal 
Tonic Movement Absence Absence Absence 
Clonic Movement Absence Absence Absence 
Laxative action Absence Absence Moderate 
Touch Response Normal Normal Normal 
Response to Sound Normal Response 
Normal 
Response Normal Response 
Response to Light Normal Response 
Normal 
Response Normal Response 
Mobility Normal Normal Normal 
Respiratory Distress Nil Nil Nil 
Skin Color Normal Normal Normal 
Stereotype behavior Absence Absence Absence 
Piloerection Absence Absence Absence 
Limb Paralysis Absence Absence Absence 
Posture Normal Normal Normal 
Open field behavior Normal Normal Normal 
Gait Balancing Normal Normal Normal 
Freezing Behaviour Absent Absent Absent 
Sings of Stress and 
Anxiety None Observed None Observed None Observed 
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Muscular coordination Normal Normal Normal 
Muscle grip Normal Normal Normal 
Sedation Absence Absence Absence 
Social Behavior Normal Normal Normal 
Urine Analysis No Abnormality No Abnormality No Abnormality 
Urine Colour Yellowish Yellowish Yellowish 
Urine pH 7 6 6 
Urine -
Glucose                         Absence Absence Absence 
Urine -
Ketones                        Absence Absence Absence 
Urine- 
Bilirubin                         Absence Absence Absence 
Urine-Blood  Cells       Negative Negative Negative 
Urine - Pus cells Negative Negative Negative 
Mortality Nil Nil Nil 
 
Effect of  Sarakondrai Chooranam on Body weight of Rats in Sub-acute toxicity 
study 
Group I Before Treatment Weight in Gms After Treatment Weight in Gms 
Mean 187.3 198.7 
Std. Deviation 5.645 6.408 
Std. Error 2.305 2.616 
Group II Before Treatment Weight in Gms After Treatment Weight in Gms 
Mean 185.3 197.3 
Std. Deviation 3.933 4.082 
Std. Error 1.606 1.667 
Group III Before Treatment After Treatment Weight in Gms 
Mean 180.3 192.7 
Std. Deviation 6.377 6.802 
Std. Error 2.603 2.777 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). Control and 
treatment groups were compared statistically using one way ANOVA followed by 
Dunnett’s test. 
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Quantitative data on the food and water intake of rats treated with Sarakondrai 
Chooranam for 28 days in Sub-acute toxicity study 
GROUP I Food intake Water intake 
Mean 19.25 41.25 
Std. Deviation 3.072 1.371 
Std. Error 1.536 0.6855 
GROUP II Food intake Water intake 
Mean 18.25 27.75 
Std. Deviation 2.846 1.316 
Std. Error 1.423 0.6579 
GROUP III Food intake Water intake 
Mean 16.83 39.25 
Std. Deviation 3.491 1.344 
Std. Error 1.745 0.6719 
 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). Control and 
treatment groups were compared statistically using one way ANOVA followed by 
Dunnett’s test. 
Effect of Sarakondrai Chooranam on Haematology profile of rats in sub-acute 
toxicity study. 
GROUP 
 I 
 WBC 
count 
(×10
3
 µl) 
RBC  
(×10 
6
 µl) 
PLT 
 (×10 
3
 µl) 
MCV     
(fl) 
MCH    
(pg) 
MCHC 
(g/dl) 
HGB 
(g/dl) 
Mean 13.5 7.217 684.3 63.22 19.37 31.47 11.88 
Std. 
Deviation 1.536 1.559 90.86 4.269 3.838 2.083 2.109 
Std. Error 0.6272 0.6364 37.09 1.743 1.567 0.8504 0.8612 
GROUP  
II 
 WBC 
count 
(×10
3
 µl) 
RBC  
(×10 
6
 µl) 
PLT 
 (×10 
3
 µl) 
MCV     
(fl) 
MCH    
(pg) 
MCHC 
(g/dl) 
HGB 
(g/dl) 
Mean 9.983 6.417 764.3 59.12 20.37 32.65 11.1 
Std. 
Deviation 1.495 1.294 137.4 6.003 1.283 1.528 1.231 
Std. Error 0.6101 0.5282 56.1 2.451 0.5239 0.6238 0.5027 
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GROUP 
III 
 WBC 
count 
(×10
3
 µl) 
RBC 
 (×10 
6
 µl) 
PLT 
 (×10 
3
 µl) 
MCV     
(fl) 
MCH    
(pg) 
MCHC 
(g/dl) 
HGB 
(g/dl) 
Mean 11.08 7.033 511.8 61.12 23.03 32.12 11.65 
Std. 
Deviation 2.227 1.559 98.96 5.253 3.16 1.552 2.593 
Std. Error 0.909 0.6365 40.4 2.145 1.29 0.6337 1.059 
 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). Control and 
treatment groups were compared statistically using one way ANOVA followed by 
Dunnett’s test. 
 
Effect of Sarakondrai Chooranam on Haematology profile of rats in sub-acute 
toxicity study. 
GROUP I 
Lymph        
(%) 
Mon            
(%) 
Neutrophils     
(X 
10
3
/mm
3
) 
Eosinophils 
(%) 
Basophils 
(%) 
MPV 
(fl) 
Mean 70.74 2.1 2.533 1.3 0.5 6.267 
Std. 
Deviation 6.62 0.7874 1.001 0.2828 0.5477 1.283 
Std. Error 2.702 0.3215 0.4088 0.1155 0.2236 0.5239 
GROUP II 
Lymph        
(%) 
Mon            
(%) 
Neutrophils     
(X 
10
3
/mm
3
) 
Eosinophils 
(%) 
Basophils 
(%) 
MPV 
(fl) 
Mean 70.92 3.9 1.967 1.633 0.1667 6.983 
Std. 
Deviation 5.513 1.345 0.7528 0.3445 0.4082 0.8495 
Std. Error 2.251 0.5489 0.3073 0.1406 0.1667 0.3468 
GROUP 
III 
Lymph        
(%) 
Mon            
(%) 
Neutrophils     
(X 
10
3
/mm
3
) 
Eosinophils 
(%) 
Basophils 
(%) 
MPV 
(fl) 
Mean 72.65 2.55 2.383 1.343 0.3333 6.65 
Std. 
Deviation 8.053 1.346 1.098 0.343 0.5164 1.013 
Std. Error 3.288 0.5494 0.4483 0.14 0.2108 0.4137 
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Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). Control and 
treatment groups were compared statistically using one way ANOVA followed by 
Dunnett’s test. 
 
Effect of Sarakondrai Chooranam on Serum Bio-chemistry profile of rats in sub-
acute toxicity study 
GROUP 
 I 
Blood 
sugar ® 
(mg/dl) 
BUN 
(mg/dl) 
 Serum 
creatinine 
(mg/dl) 
Serum 
total 
cholesterol 
(mg/dl) 
Serum 
triglycerides 
level (mg/dl) 
Serum 
HDL 
cholesterol 
(mg/dl) 
Serum 
LDL 
cholesterol 
(mg/dl) 
Serum 
VLDL 
cholesterol 
(mg/dl) 
Mean 86.17 11.17 0.6167 117.2 80.67 68.67 29.67 16.82 
Std. 
Deviation 8.931 3.251 0.2994 16.98 11.93 12.45 17.75 1.707 
Std. Error 3.646 1.327 0.1222 6.93 4.869 5.084 7.246 0.6969 
 
 
GROUP  
II 
Blood 
sugar ® 
(mg/dl) 
BUN 
(mg/dl) 
 Serum 
creatinine 
(mg/dl) 
Serum 
total 
cholesterol 
(mg/dl) 
Serum 
triglycerides 
level (mg/dl) 
Serum 
HDL 
cholesterol 
(mg/dl) 
Serum 
LDL 
cholesterol 
(mg/dl) 
Serum 
VLDL 
cholesterol 
(mg/dl) 
Mean 94.17 12.5 0.75 105.5 81.83 69.17 26 13.6 
Std. 
Deviation 6.432 3.017 0.2074 17.83 11.51 9.496 5.404 2.589 
Std. Error 2.626 1.232 0.08466 7.279 4.7 3.877 2.206 1.057 
GROUP 
III 
Blood 
sugar ® 
(mg/dl) 
BUN 
(mg/dl) 
 Serum 
creatinine 
(mg/dl) 
Serum 
total 
cholesterol 
(mg/dl) 
Serum 
triglycerides 
level (mg/dl) 
Serum 
HDL 
cholesterol 
(mg/dl) 
Serum 
LDL 
cholesterol 
(mg/dl) 
Serum 
VLDL 
cholesterol 
(mg/dl) 
Mean 76.67 16.5 0.75 119.3 70.83 47.67 53.67 19.05 
Std. 
Deviation 14.17 4.764 0.2168 18.38 8.75 4.412 7.789 4.723 
Std. Error 5.783 1.945 0.08851 7.504 3.572 1.801 3.18 1.928 
 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). Control and 
treatment groups were compared statistically using one way ANOVA followed by 
Dunnett’s test. 
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Effect of Sarakondrai Chooranam on Serum Bio-chemistry profile of rats in sub-
acute toxicity study 
GROUP I 
Serum total 
protein 
(g/dl) 
Serum 
albumin 
(g/dl) 
(AST)  
(IU/ml) 
(ALT) 
(IU/L) 
(ALP) 
(IU/L) 
Mean 4.917 3.717 99.5 32.83 247 
Std. Deviation 2.043 1.08 22.51 10.57 20.91 
Std. Error 0.834 0.4408 9.19 4.316 8.536 
GROUP II 
Serum total 
protein 
(g/dl) 
Serum 
albumin 
(g/dl) 
(AST)  
(IU/ml) 
(ALT) 
(IU/L) 
(ALP) 
(IU/L) 
Mean 5.5 2.983 107.8 21.33 107.2 
Std. Deviation 0.7668 0.6242 19.96 6.772 18.13 
Std. Error 0.313 0.2548 8.15 2.765 7.4 
GROUP III 
Serum total 
protein 
(g/dl) 
Serum 
albumin 
(g/dl) 
(AST)  
(IU/ml) 
(ALT) 
(IU/L) 
(ALP) 
(IU/L) 
Mean 4.917 2.267 134.5 39.83 158.8 
Std. Deviation 1.356 0.4844 5.822 7.305 72.28 
Std. Error 0.5534 0.1978 2.377 2.982 29.51 
 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). Control and 
treatment groups were compared statistically using one way ANOVA followed by 
Dunnett’s test. 
 
Quantitative data on absolute organ weight of rats treated with Sarakondrai 
Chooranam for 28 days in Sub-acute toxicity study. 
 
 
GROUP 
I 
HEART 
(gms) 
 LIVER 
(gms) 
KIDNEYS 
(gms) 
SPLEEN 
(gms) 
BRAIN   
(gms) 
LUNG    
(gms) 
STOMACH               
(gms) 
TESTES 
(gms) 
UTERUS 
& 
OVARY 
(gms) 
Mean 0.5417 6.62 1.507 0.4 1.667 1.633 1.183 2.533 1.133 
Std. 
Deviation 0.05269 0.7811 0.1987 0.1265 0.1751 0.1633 0.2639 0.9074 0.4041 
Std. Error 0.02151 0.3189 0.0811 0.05164 0.07149 
0.0666
7 0.1078 0.5239 0.2333 
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GROUP 
II 
HEART 
(gms) 
 LIVER 
(gms) 
KIDNEYS 
(gms) 
SPLEEN 
(gms) 
BRAIN   
(gms) 
LUNG    
(gms) 
STOMACH               
(gms) 
TESTES 
(gms) 
UTERUS 
& 
OVARY 
(gms) 
Mean 0.6967 5.203 1.505 0.6333 1.75 1.7 1.25 3.033 1.367 
Std. 
Deviation 0.1071 0.665 0.1634 0.1633 0.1761 0.1549 0.2881 0.5859 0.2082 
Std. Error 0.04372 0.2715 0.06672 0.06667 0.07188 
0.0632
5 0.1176 0.3383 0.1202 
GROUP 
III 
HEART 
(gms) 
 LIVER 
(gms) 
KIDNEYS 
(gms) 
SPLEEN 
(gms) 
BRAIN   
(gms) 
LUNG    
(gms) 
STOMACH               
(gms) 
TESTES 
(gms) 
UTERUS 
& 
OVARY 
(gms) 
Mean 0.68 7.173 1.322 0.6167 1.65 1.6 1.417 2.633 1.2 
Std. 
Deviation 0.1471 0.5425 0.1933 0.1169 0.1049 0.3286 0.4167 0.8327 0.1 
Std. Error 0.06006 0.2215 0.07893 0.04773 0.04282 0.1342 0.1701 0.4807 0.05774 
 
 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females) for Heart, 
Liver, Kidney, Brain, Spleen, Lung, Stomach. Values are mean ± S.D (n = 3 per group 
per sex ) for testes, ovary and uterus for Control and treatment groups were compared 
statistically using one way ANOVA followed by Dunnett’s test. 
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Histopathology of Brain (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
 
         GROUP I               GROUP II     GROUP III  
High Power Magnification 40X 
   
         GROUP I   GROUP II      GROUP III 
 
Histopathology of Heart (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
 
          GROUP I   GROUP II     GROUP III 
High Power Magnification 40X 
 
         GROUP I   GROUP II     GROUP III 
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Histopathology of Kidney (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
 
         GROUP I   GROUP II         GROUP III 
High Power Magnification 40X 
 
          GROUP I   GROUP II          GROUP III 
 
Histopathology of Liver (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
 
GROUP I      GROUP II          GROUP III  
High Power Magnification 40X 
   
          GROUP I   GROUP II                      GROUP III  
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Histopathology of Kidney (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X  
       
          GROUP I     GROUP II         GROUP III 
 High Power Magnification 40X 
 
         GROUP I    GROUP II         GROUP III 
 
Histopathology of Spleen (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
 
           GROUP I   GROUP II         GROUP III  
High Power Magnification 40X 
 
           GROUP I                GROUP II         GROUP III  
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Histopathology of Stomach (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
 
         GROUP I   GROUP II           GROUP III  
High Power Magnification 40X 
 
          GROUP I              GROUP II           GROUP III  
 Histopathology of Uterus (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
 
     GROUP I          GROUP II                  GROUP III              
High Power Magnification 40X 
    
          GROUP I   GROUP II           GROUP III  
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Histopathology of Ovary (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
 
         GROUP I   GROUP II                  GROUP III 
High Power Magnification 40X 
 
         GROUP I                GROUP II                   GROUP III  
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Effect of SKC on Hematology Profile of Phenyl hydrazine induced Anaemic rats. 
GROUP I RBC                   (×10 
6
µl) WBC (×10
3 
µl) 
HGB (g/dl) HCT (%) 
Mean 7.417 8.05 12.67 48 
Std. Deviation 0.4916 0.5128 1.211 3.033 
Std. Error 0.2007 0.2094 0.4944 1.238 
GROUP II RBC                   (×10 
6
µl) WBC (×10
3 
µl) 
HGB (g/dl) HCT (%) 
Mean 4.517 6.133 7 19 
Std. Deviation 0.5672 0.3266 0.8944 1.414 
Std. Error 0.2315 0.1333 0.3651 0.5774 
GROUP III RBC                   (×10 
6
µl) WBC (×10
3 
µl) 
HGB (g/dl) HCT (%) 
Mean 5.567 7.217 8.667 24 
Std. Deviation 0.2251 0.3189 0.8165 2.098 
Std. Error 0.09189 0.1302 0.3333 0.8563 
GROUP IV RBC                   (×10 
6
µl) WBC (×10
3 
µl) 
HGB (g/dl) HCT (%) 
Mean 6 7.7 10.67 29.33 
Std. Deviation 0.2449 0.3578 1.033 2.066 
Std. Error 0.1 0.1461 0.4216 0.8433 
Values are mean ± S.D / S.E (n = 6 per group) 
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Pharmacological Evaluation of Sarakondrai Chooranam on Phenyl hydrazine 
induced Anaemia in wistar rats. 
Name: Dr.M.Shanmuga priya 
IAEC: SU/CLATR/IEAC/VII/052/2016 
 
Animals 
Healthy adult Wistar albino female rats weighing between 220-240 g were 
used for the study.  The animals were housed in poly propylene cages and were kept in 
well ventilated with 100% fresh air by air handling unit. A 12 light / dark cycle were 
maintained. Room temperature was maintained between 22 + 2
o  
C and relative 
humidity 50–65%. They were provided with food (Sai feeds, Bangalore, India) and 
water ad libitum. All the animals were acclimatized to the laboratory for 7 days prior 
to the start of the study.The experimental protocol was approved by The Institutional 
Animal Ethics Committee of Sathyabama University, Chennai, Tamil Nadu, India. 
IAEC: SU/CLATR/IEAC/VII/052/2016. 
Experimental Methodology 
Animal belongs to group I received normal saline 5ml/kg. Group II rats were 
treated with Phenylhydrazine (PHZ) 40 mg / kg (i.p) for two days (Day1 and Day 2) 
and were served as disease control. Animal belongs to group III received PHZ 
injection 40mg/kg (i.p) and treated with 200 mg/kg Sarakondrai Chooranam from 3rd 
to 16th Day. Whereas animal belongs to group IV treated with 400 mg/kg Sarakondrai 
Chooranam from 3rd to 16th Day and served as treatment group. 
 
Induction of Anaemia 
Induction of Anaemia in rats was performed  by  intraperitoneal administration 
of 40mg/kg of phenylhydrazine (PHZ) for two days (Day1 and Day2). 
  
Sample Collection 
At the end of the study, before sacrifice, the animals were fasted for overnight 
with free access to water. Animals were sacrificed with excess anesthesia. Blood 
samples were collected from retro orbital sinus puncture and stored in EDTA 
(ethylenediamine –tetra acetate) test tubes for Hematological analysis. Bone marrow 
of control and treatment group animals were collected using fine needle aspiration 
technique for further processing. 
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Biochemical Parameter 
At the end of the study blood will be collected by ocular puncture after 
overnight fasting animals. The blood parameters such as red blood cell count (RBC), 
white blood cell count (WBC), haemoglobin concentration (Hb) and haematocrit was 
determined using Mindray BC 2800 hematology analyzer. 
 
Bone Marrow Smear 
 About 0.2 ml of smear aspirated from the femur thigh bone of the 
experimental animal was dropped onto the glass slide and made into thin smear allow 
the smear to dry. Dried smear was stained with leishman stain and washed. Followed 
by this cedar wood oil was placed on to the smear and was observed microscopically.   
 
 
 
Microscopic View of Bone Marrow Smear of control and treatment group rats 
 
      Control Sample                               Phenyl hydrazine induced Group 
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Phenyl hydrazine + 200mg/kg of SKC      Phenyl hydrazine + 400mg/kg of SKC 
 
 
 
 
 
 
 
 
 
 
 
 
 
PATHOLOGY REPORT 
 Bulky marrow with dense cellular portions were observed and active zones of 
erythropoiesis were observed in sample belongs to group I. Bone marrow 
smear of group I reveals normal Eosinophilic myelocyte and basophilic 
myelocyte. 
 Hyperplasic condition of marrow with increased adipocyte cells replaced the 
marrow space was observed. Megakaryocyte appears very minimal in number 
with erythroid precursors, and granulocytic precursors was observed in sample 
belongs to group II.   
 Increased network of erythroblastic islets were observed, Central reticular cells 
appears normal long and slender in nature. Increased number of erythroblastic 
islets with wavy zone of erythropoiesis was observed in sample belongs to 
group III and IV. 
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Sarakondrai chooranam chloroform extract 
Stationary Phase - Silica Gel 60 F254 
Mobile Phase - Toluene : Ethyl acetate :  (5:1 v/v) 
 
 
 
 
 
UV 254 nm UV 366 nm 575 nm (Derivatized) 
Color Rf  value(s) Color Rf  value(s) Color Rf value(s) 
Green 0.02 Ash 0.03 Grey 0.02 
Green 0.11 Maroon 0.21 Light Ash 0.10 
Green 0.21 Blue 0.31 Light Pink 0.35 
Green 0.34 Red 0.36 Light Blue 0.43 
Green 0.42 Red 0.39 Light Blue 0.56 
Green 0.87 Sky Blue 0.41 Light Blue 0.66 
Green 0.98 Maroon 0.51 Violet 0.72 
  Light Red 0.60 Grey 0.75 
  Light Red 0.68 Black 0.97 
  Ash 0.72   
  Pink 0.76   
  Sky Blue 0.80   
  Maroon 0.82   
  Red 0.88   
  Ash 0.98   
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HPTLC Chromatogram @ 366 nm: 
 
Peak Table @ 366 nm:  
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3D Chromatogram @ 366 nm: 
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BIO-CHEMICAL  ANALYSIS  OF  TRIAL MEDICINE 
Preparation  of  Sodium Carbonate extract: 
     2 gm of the sample drug is mixed with 5 gm of Sodium carbonate and taken in a 
100 ml beaker and 20 ml of distilled water is added. The solution is boiled for 10 
minutes, cooled and then filtered. The filtrate is called sodium carbonate extract. 
S.No EXPERIMENT OBSERVATION INFERENCE 
TEST FOR ACID RADICALS 
1. a) Test for Sulphate 
2ml of the above prepared extract is taken 
in a test tube. To this add 2ml of 4% 
Ammonium oxalate solution. 
Absence of White 
Precipitate 
Absent 
b) 2ml of extract is added with 2ml of dilute 
hydrochloric acid until the effervescence 
ceases off. Then 2ml barium chloride 
solution is added. 
Absence of White 
Precipitate 
Absent 
2 Test for Chloride 
2ml of extract is added with dilute nitric 
acid till the effervescence ceases. Then 
2ml of silver nitrate solution is added. 
Absence of White 
Precipitate 
 
Absent 
3 Test for Phosphate 
2ml of the extract is treated with  
2 ml of Ammonium molybdate solution 
and 2ml of concentrated nitric acid. 
Absence of 
Yellow 
precipitate 
 
Absent 
4 Test for Carbonate 
2ml of the extract is treated with 2ml of 
magnesium sulphate solution. 
Absence of white 
precipitate 
Absent 
5 Test for Sulphide 
1 gm of the substance is treated 
with 2ml of concentrated Hcl. 
Absence of 
Rotten 
egg smelling 
Absent 
6 Test for Nitrate 
1gm of the substance is heated with 
copper turnings and concentrated 
Absence of 
reddish 
brown gas. 
Absent 
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sulphuric acid and viewed the test tube 
vertically down. 
7 Test for Fluoride and oxalate 
2ml of the extract is added with 2ml of 
dilute acetic acid and 2ml of calcium 
chloride solution and heated. 
Absence of white 
precipitate 
Absent 
8 5 drops of clear solution is added with 
2ml of diluted sulphuric acid and slightly 
warmed to this, 1 ml of dilute potassium 
permanganate solution is added. 
Absence of 
KMNO4 solution 
Decolourisation  
Absent 
 
9 Test for Nitrite 
3 drops of the extract is  placed on a filter 
paper. On that, 2 drops of Acetic Acid 
and 2 drops of Benzidine solution is 
placed. 
Absence of 
yellowish red 
colour 
Absent 
10 Test for Borate 
2 pinches of the substance is made into 
paste by using Sulphuric acid and 
Alcohol (95%) and introduced into the 
blue flame. 
Absence of Green 
tinged flame 
Absent 
 
TEST FOR BASIC RADICALS 
1 Test for lead 
2 ml of the extract is added with 2 ml of 
Potassium iodide solution. 
Absence of 
Yellow 
precipitate 
Absent 
2.a) Test for Copper 
One pinch of substance is made into paste 
with concentrated Hydrochloric acid in a 
watch glass and introduced into the non 
luminous part of the flame. 
Presence of 
Bluish 
green coloured 
flame. 
Present 
b) 2ml of the extract is added with excess of 
Ammonia solution 
Presence of deep 
blue colour. 
Present 
3 Test for Aluminium Absence of White Absent 
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To the 2 ml of extract. Sodium 
Hydroxide solution is added in drops to 
excess. 
Precipitate. 
4.a) Test for Iron 
To the 2 ml of extract, 2 ml of 
Ammonium Thiocyanate Solution is 
added. 
Blood red colour Present 
b) To the 2 ml of extract, 2 ml of 
Ammonium Thiocyanate solution and 2 
ml of concentrated Nitric Acid is added. 
Blood red colour 
obtained 
Present 
5 Test for Zinc 
To the 2 ml of extract Sodium Hydroxide 
solution is added in drops to excess 
Absence of White 
precipitate. 
Absent 
6 Test for Calcium 
2 ml of the extract is added with 2 ml of 
4% Ammonium Oxalate solution. 
 Absence of 
White Precipitate.  
Absent 
7 Test for Magnesium 
2ml of extract, Sodium Hydroxide 
solution is added in drops to excess. 
Absence of White 
precipitate. 
Absent 
8 Test for Ammonium 
2 ml of extract few ml of  Nessler’s 
Reagent and excess of Sodium Hydroxide 
solution are added. 
Absence of 
Reddish brown 
Precipitate 
Absent 
9 Test for Potassium 
A pinch of substance is treated with 2 ml 
of Sodium Nitrite solution and then 
treated with 2 ml of Cobal Nitrate in 30% 
glacial Acetic acid. 
Absence of 
Yellow 
precipitate 
 
Absent 
 
 
10 Test for Sodium 
2 pinches of the substance is made into 
paste by using Hydrochloric acid and 
introduced into the blue flame. 
Absence of 
Yellow 
colour flame 
Absent 
11 Test for Mercury Absence of Absent 
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2 ml of the extract is treated with 2 ml of 
Sodium Hydroxide solution. 
yellow 
Precipitate 
12 Test for Arsenic 
2 ml of extract is treated with 2 ml of 
silver Nitrate solution. 
Absence of 
Yellow 
precipitate 
Absent 
13 Test for Starch 
2ml of extract is treated with weak iodine 
solution 
Absence of Blue 
colour 
Absent 
14 Test of Reducing Sugar 
5ml  of  Benedicts qualitative solution is 
taken in a test tube and allowed to boil 
for 2 minutes and added 10 drops of the 
extract and again boiled for 2 minutes. 
The colour changes are noted. 
Green colour 
obtained 
Present 
15 Test of the alkaloids 
2ml of the extract is treated with 2ml of 
potassium lodide solution. 
Presence  of Red 
colour 
Present 
 
 
16 Test of the proteins 
2ml of the extract is treated with 2ml of 
5% NaOH, mix well and add 2 drops of 
copper sulphate solution. 
Absence of Violet 
colour 
Absent 
 
RESULTS: 
  The given sample ( Sarakondrai  Chooranam ) contains : 
1. Iron 
2. Copper 
3.  Reducing sugar 
4. Alkaloids. 
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CLINICAL PROGNOSIS 
Treatment for Pitha Paandu: 
The most popular non parametric statistical tool, namely, McNemar Test 
analysis has been employed to analyses the effectiveness with the help of a hypothesis. 
 
S.No Signs&Symptoms      Before Treatment After Treatment 
n% n% 
1. Pallor of  conjunctiva  and nail  bed 40(100) 8(20)** 
2. Fatigue 40(100) 3(7.5)** 
3. Loss  of  appetite 40(100) 4(10)** 
4. Dyspnea  on exertion 40(100) 6(15)** 
5. Headache 18(45) 5(12.5)** 
6. Glossitis 13(32.5) 6(15)* 
7. Constipation 20(50) 0(0)** 
8. Giddiness 20(50) 0(0)** 
9. Tachycardia 18(45) 4(10)* 
10. Dimness  of  vision 5(12.5) 3(7.5) 
    McNemat test, C.I: 95%,  *P<0.05; **P<0.01 
Software: spss17 version 
Number of cases: 40 
Inference:  
Since the p value is significant in all signs and symptoms except dimness of 
vision. So there is significant reducing of signs & symptoms except dimness of vision 
among the patients for the treatment of Pitha Paandu (Iron deficiency anaemia). Hence 
it is concluded that the treatment was effective and significant.  
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HAEMOGLOBIN  LEVEL: 
Effect of Sarakondrai Chooranam on Hb level (gm/dl) in human subjects  
      S. no BeforeTreatment(gms/dl) AfterTreatment(gms/dl) 
1 10.0 12.1 
2 10.0 13.2 
3 9.8 11.9 
4 9.0 12.0 
5 8.3 10.9 
6 8.8 11.0 
7 10.0 13.1 
8 9.1 11.3 
9 9.0 12.3 
10 9.6 12.8 
11 9.2 12.4 
12 7.5 9.8 
13 8.6 11.3 
14 8.7 11.8 
15 8.6 12.7 
16 9.9 12.0 
17 9.5 12.1 
18 9.8 12.9 
19 10.0 12.6 
20 9.0 12.2 
21 9.8 12.9 
22 8.6 11.8 
23 10.0 13.2 
24 10.0 12.6 
25 10.0 12.9 
26 9.5 12.5 
27 8.0 11.1 
28 10.0 13.2 
29 10.0 13.1 
30 9.9 12.9 
31 10.0 13.3 
32 10.0 12.9 
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33 9.8 12.6 
34 10.0 12.2 
35 8.0 11.1 
36 10.0 13.5 
37 7.6 8.8 
38 10.0 12.9 
39 10.0 13.0 
40 8.8 10.4 
 
 
Software: spss17 version 
Variables: Hb level (gm/dl) – before treatment, after treatment 
Number of cases: 40 
Test: Paired t test 
Confidence Interval: 95% 
Correlation coefficient (r): 0.897 
Before and after treatment mean difference ± SEM: 2.92± 0.07. 
P Value (2 tailed): p<0.001. 
Inference:  
      Since the P value is highly significant (<0.001), the hypothesis is not accepted.  So 
the treatment was significantly improving the Hb level among the patients for the 
treatment of Pitha Paandu.  
 
 
 
 
 
 
 
 
 
 
 
 
140 
 
 
அ஧சிணர் சித்஡ ஥ருத்து஬க் கல்லூரி, சசன்னண-106. 
அநிஞர் அண்஠ா ஥ருத்து஬஥னண, சசன்னண-106 
தித்஡ தாண்டு ந஢ாய்க்காண சித்஡ ஥ருந்஡ின் (சரக்க ொன்றை சூரணம்) தரிகரிப்பு ஡ிநனணக் 
கண்டநியும் ஥ருத்து஬ ஆய்஬ிற்காண ந஢ா஦ாபி஦ின் தகவல் படிவம்.  
ஒப்பு஡ல் தடி஬ம். 
ஆய்஬ாப஧ால் சான்நபிக்கப்தட்டது. 
   ஢ான் இந்஡ ஆய்ன஬ குநித்஡ அனணத்து ஬ித஧ங்கனபயும் ந஢ா஦ாபிக்குப் புரியும் ஬னக஦ில் 
எடுத்துன஧த்ந஡ன்.  
ந஡஡ி:                                னகச஦ாப்தம்: 
இடம்:                                சத஦ர்: 
 
                     ந஢ா஦ாபி஦ின் ஒப்பு஡ல் 
    என்ணிடம் இந்஡ ஥ருத்து஬ ஆய்஬ின் கா஧஠த்ன஡யும், ஥ருந்஡ின் ஡ன்ன஥ன஦யும், ஥ருத்து஬ 
஬஫ிமுனநன஦யும் ஥ற்றும் ச஡ாடர்ந்து எணது உடல் இ஦க்கத்ன஡ கண்கா஠ிக்கவும், அ஡னண 
தாதுகாக்கவும் த஦ன்தடும் ஥ருத்து஬ ஆய்வுக்கூட தரிநசா஡னணகள் தற்நி ஡ிருப்஡ி அபிக்கும் 
஬னக஦ில் ஆய்வு ஥ருத்து஬஧ால் ஬ிபக்கிக் கூநப்தட்டது. 
 
    ஢ான் இந்஡ ஥ருத்து஬ ஆய்஬ின் நதாது , கா஧஠ம் எதுவும் கூநா஥ல், எப்நதாது 
ந஬ண்டு஥ாணாலும் இந்஡ ஆய்஬ினிருந்து என்னண ஬ிடு஬ித்துக் சகாள்ல௃ம் உரின஥ன஦ 
ச஡ரிந்஡ிருக்கிநநன். ஢ான் என்னுனட஦ சு஡ந்஡ி஧஥ாக ந஡ர்வு சசய்யும் உரின஥ன஦க் சகாண்டு 
தித்஡ தாண்டு ந஢ாய்க்காண  சரக்க ொன்றை சூரணம்   தரிகரிப்புத் ஡ிநனணக் கண்டநியும் 
஥ருத்து஬ ஆய்஬ிற்கு என்னண உட்தடுத்஡ ஒப்பு஡ல் அபிக்கிநநன்.  
 
                    
ந஡஡ி:                                        னகச஦ாப்தம்: 
இடம்:                                        சத஦ர்: 
                                                    சாட்சிக்கா஧ர் னகச஦ாப்தம்: 
                                              சத஦ர்: 
                                              உநவுமுனந:  
                   
துனநத்஡னன஬ர் னகச஦ாப்தம்:                ஆய்஬ாபர் னகச஦ாப்தம்: 
 
 
 
141 
 
 
          
GOVERNMENT SIDDHA MEDICAL COLLEGE 
ARIGNAR ANNA GOVERNMENT HOSPITAL OF INDIAN MEDICINE 
CHENNAI – 600 106 
A CLINICAL STUDY ON 
“SARAKONDRAI CHOORANAM” IN THE TREATMENT 
OF “PITHA PAANDU”(“Iron deficiency anaemia”). 
 
                                           INFORMED CONSENT FORM 
I have read the foregoing information, or it has been read to me. I have had the 
opportunity to ask questions about it and any questions I have asked have been 
answered to my satisfaction. 
            I   consent voluntarily to participate in this study and understand that I have the   
right to withdraw from the study at any time without in any way it affecting my further 
medical care. 
I  have  received  a copy of the information sheet/consent form. 
 
Date: 
Station: 
Signature of the Participant: 
 
 
 
Signature of the Guide:                                                 Signature of the Investigator 
 
 
 
 
 
 
 
142 
 
 
CASE SHEET PROFORMA FOR PITHA PAANDU  
GOVT.SIDDHA MEDICAL COLLEGE & HOSPITAL 
CHENNAI-106 
POST GRADUATE DEPARTMENT BRANCH –I MARUTHUVAM 
Duration: 2015-2017 
 
Op No / Ip No  :    Occupation  : 
Ward No  :    Income  : 
Bed No  :    Nationality  : 
Name   :    Religion  : 
Age   :    D.O.A   : 
Sex   :    D.O.D   : 
Address  :    Diagnosis  : 
 
1. Complaints and duration  : 
 
2. History of present illness  : 
 
3. History of past illness  : 
 
4. Personal history   : 
 
5. Occupational history  : 
 
6. Menstrual history   : 
 
7. Personal Habits   :Veg/nonveg/smoker/Alcoholic/Tobacco chewer 
 
8. Family History   : 
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GENERAL EXAMINATION 
Patient consciousness : 
Body Built : 
Nourishment : 
Pallor : 
Jaundice : 
Cyanosis : 
Clubbing : 
JVP : 
Tracheal deviation : 
Pedal oedema : 
Lymph adenopathy : 
 
Vital Signs 
Body Temp : 
Pulse : 
Respiratory rate : 
Blood Pressure : 
Weight : 
 
SIDDHA ASPECT  
NILAM 
Kurinchi : 
Mullai : 
Marutham : 
Neithal : 
Palai : 
 
PARUVA KALAM 
Kaar : 
Koothir : 
Munpani : 
Pinpani : 
Elavenil : 
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Muduvenil : 
 
YAAKKAI (Udal)                                                                                  
Vaatham  : 
Pittham  : 
Kabam   : 
Kalappu  : 
 
GUNAM 
Satthuvam  : 
Rajotham  : 
Thamasam  : 
 
PORI/PULANGAL (SENSORY ORGANS) 
Mei –Sensation   : 
Vaai – Taste    : 
Kan – Vision     : 
Mooku - Smell   : 
Sevi – Hearing   : 
 
KANMENTHRIYAM/KANNMA VIDAYAM [MOTOR ORGANS] 
Kai- Dhaanam    : 
Kaal-Kamanam   : 
Vaai-Vasanam   : 
Eruvaai- Visarkkam   : 
Karuvaai-Aanantham   : 
 
UTHKAAYA ATHAKAAYAM 
Puyam[forearm]   : 
Sayam[arm]    : 
Kaal[leg]    : 
Paaatham[feet]   : 
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UYIR THATHUKKAL 
A.VATHAM 
 Piranan   : 
 Abanan   : 
 Viyanan   : 
 Udanan   : 
 Samanan   : 
 Nagan    : 
 Koorman   : 
 Kirukaran   : 
Devathathan   : 
Thananjeyan   : 
 
B.PITHAM 
Anar pitham   : 
Ranjaga pitham  : 
Saathaga pitham  : 
Pirrasaga pitham  : 
Alosaga pitham  : 
 
C.KABAM 
Avalambagam   : 
Kilethagam   :  
Pothagam   : 
Tharpagam   : 
Santhigam                      : 
   
UDALTHAATHUKKAL 
Saaram   : 
Senner    : 
Oon    : 
Kozhuppu   : 
Enbu    : 
Moolai    : 
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Sukkilam/Suronitham  : 
  
ENVAGAI THERVUGAL 
1.Naa    : 
2.Niram   : 
3.Mozhi   : 
4.Vizhi   : 
5.Sparisam   : 
6.Malam   : 
7.Moothiram 
a)Neer Kuri  : 
 b)Nei Kuri  : 
8.Naadi   : 
 
MALAM 
 Niram    : 
 Edai    : 
 Erugal    : 
 Elagal    : 
 
MOOTHIRAM 
 1.Neerkuri 
  Niram   : 
  Manam  : 
  Edai   : 
  Nurai   : 
  Enjal   : 
  
2.Neikuri 
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CLINICAL SIGNS AND SYMPTOMS OF PITHA PAANDU 
Symptoms 
Before 
Treatment 
 
After Treatment 
 
 
7 
days 
 
14 
days 
 
21 
days 
 
28 
days 
 
35 
days 
 
42 
days 
 
48 
days 
1. Pallor of 
conjunctiva and 
nail bed 
 
    
    
2. Fatigue 
 
    
    
3. Loss of appetite 
 
    
    
4. Dyspnoea on       
exertion 
 
    
    
5.Head ache 
 
    
    
6. Glossitis 
    
    
7. Giddiness 
 
    
    
8. Tachycardia 
 
    
    
9.Dimness of vision 
 
    
    
10.Tiredness     
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INVESTIGATIONS    
 
1.BLOOD BEFORE TREATMENT AFTER TREATMENT 
TC   
DC   
Hb   
Blood sugar   
ESR (1/2 hr and 1 hr)   
Blood urea   
Serum cholesterol   
 
   
2.RED BLOOD CELL 
COUNT 
BEFORE TREATMENT AFTER TREATMENT 
  
   
 
 3.SPECIFIC 
INVESTIGATIONS 
BEFORE TREATMENT AFTER TREATMENT 
PCV   
MCV   
MCH              
MCHC   
 
  
   4. URINE 
 Albumin 
 Sugar 
 Deposits 
 
     5. MOTION 
 Ova 
 Cyst 
 Occult Blood 
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CASE SUMMARY 
 
 
DIAGNOSIS 
 
 
TRIAL DRUG:  SARAKONDRAI  CHOORANAM 
 
Dose:  2 gm (Bds) 
 
Adjuvant: Milk 
 
Duration of Treatment: 48 days 
 
PATHIAM (Do’s and Don’ts) 
 
Prognosis at the end of the Treatment: 
 
 
 
Medical Officer Signature:       HOD 
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DATE DAILY REPORT MEDICINE 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ADVICE:  
 
 
 
 
MEDICAL OFFICER:                         H.O.D/Guide 
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